US20210000604A1 - Gender specific pharmaceuticals - Google Patents
Gender specific pharmaceuticals Download PDFInfo
- Publication number
- US20210000604A1 US20210000604A1 US17/008,185 US202017008185A US2021000604A1 US 20210000604 A1 US20210000604 A1 US 20210000604A1 US 202017008185 A US202017008185 A US 202017008185A US 2021000604 A1 US2021000604 A1 US 2021000604A1
- Authority
- US
- United States
- Prior art keywords
- recommended
- dosage
- patient group
- product
- male
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/38—Joints for elbows or knees
- A61F2/389—Tibial components
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B34/00—Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
- A61B34/10—Computer-aided planning, simulation or modelling of surgical operations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/90—Identification means for patients or instruments, e.g. tags
- A61B90/92—Identification means for patients or instruments, e.g. tags coded with colour
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/90—Identification means for patients or instruments, e.g. tags
- A61B90/94—Identification means for patients or instruments, e.g. tags coded with symbols, e.g. text
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0077—Special surfaces of prostheses, e.g. for improving ingrowth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0095—Packages or dispensers for prostheses or other implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/38—Joints for elbows or knees
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/38—Joints for elbows or knees
- A61F2/3859—Femoral components
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/38—Joints for elbows or knees
- A61F2/3877—Patellae or trochleae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/46—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor
- A61F2/4657—Measuring instruments used for implanting artificial joints
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/18—Arrangements for indicating condition of container contents, e.g. sterile condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/06—Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
- A61B17/06166—Sutures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
- A61B17/58—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
- A61B17/68—Internal fixation devices, including fasteners and spinal fixators, even if a part thereof projects from the skin
- A61B17/80—Cortical plates, i.e. bone plates; Instruments for holding or positioning cortical plates, or for compressing bones attached to cortical plates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
- A61B17/58—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
- A61B17/68—Internal fixation devices, including fasteners and spinal fixators, even if a part thereof projects from the skin
- A61B17/84—Fasteners therefor or fasteners being internal fixation devices
- A61B17/86—Pins or screws or threaded wires; nuts therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B34/00—Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
- A61B34/10—Computer-aided planning, simulation or modelling of surgical operations
- A61B2034/108—Computer aided selection or customisation of medical implants or cutting guides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/32—Joints for the hip
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/38—Joints for elbows or knees
- A61F2/3804—Joints for elbows or knees for elbows
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/40—Joints for shoulders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/42—Joints for wrists or ankles; for hands, e.g. fingers; for feet, e.g. toes
- A61F2/4202—Joints for wrists or ankles; for hands, e.g. fingers; for feet, e.g. toes for ankles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/42—Joints for wrists or ankles; for hands, e.g. fingers; for feet, e.g. toes
- A61F2/4261—Joints for wrists or ankles; for hands, e.g. fingers; for feet, e.g. toes for wrists
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/46—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor
- A61F2/4603—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor for insertion or extraction of endoprosthetic joints or of accessories thereof
- A61F2/461—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor for insertion or extraction of endoprosthetic joints or of accessories thereof of knees
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/48—Operating or control means, e.g. from outside the body, control of sphincters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
- A61F2002/2817—Bone stimulation by chemical reactions or by osteogenic or biological products for enhancing ossification, e.g. by bone morphogenetic or morphogenic proteins [BMP] or by transforming growth factors [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/30004—Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis
- A61F2002/30032—Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis differing in absorbability or resorbability, i.e. in absorption or resorption time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/30004—Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis
- A61F2002/30036—Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis differing in release or diffusion time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/3006—Properties of materials and coating materials
- A61F2002/30062—(bio)absorbable, biodegradable, bioerodable, (bio)resorbable, resorptive
- A61F2002/30064—Coating or prosthesis-covering structure made of biodegradable material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/3006—Properties of materials and coating materials
- A61F2002/30092—Properties of materials and coating materials using shape memory or superelastic materials, e.g. nitinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30108—Shapes
- A61F2002/3011—Cross-sections or two-dimensional shapes
- A61F2002/30112—Rounded shapes, e.g. with rounded corners
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30108—Shapes
- A61F2002/3011—Cross-sections or two-dimensional shapes
- A61F2002/30112—Rounded shapes, e.g. with rounded corners
- A61F2002/30125—Rounded shapes, e.g. with rounded corners elliptical or oval
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30108—Shapes
- A61F2002/3011—Cross-sections or two-dimensional shapes
- A61F2002/30138—Convex polygonal shapes
- A61F2002/30153—Convex polygonal shapes rectangular
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30329—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2002/30331—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements made by longitudinally pushing a protrusion into a complementarily-shaped recess, e.g. held by friction fit
- A61F2002/30362—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements made by longitudinally pushing a protrusion into a complementarily-shaped recess, e.g. held by friction fit with possibility of relative movement between the protrusion and the recess
- A61F2002/30364—Rotation about the common longitudinal axis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30329—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2002/30383—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements made by laterally inserting a protrusion, e.g. a rib into a complementarily-shaped groove
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30329—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2002/30383—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements made by laterally inserting a protrusion, e.g. a rib into a complementarily-shaped groove
- A61F2002/30403—Longitudinally-oriented cooperating ribs and grooves on mating lateral surfaces of a mainly longitudinal connection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30329—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2002/30476—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements locked by an additional locking mechanism
- A61F2002/305—Snap connection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30535—Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30563—Special structural features of bone or joint prostheses not otherwise provided for having elastic means or damping means, different from springs, e.g. including an elastomeric core or shock absorbers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30535—Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30604—Special structural features of bone or joint prostheses not otherwise provided for modular
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30535—Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30604—Special structural features of bone or joint prostheses not otherwise provided for modular
- A61F2002/30616—Sets comprising a plurality of prosthetic parts of different sizes or orientations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30667—Features concerning an interaction with the environment or a particular use of the prosthesis
- A61F2002/30677—Means for introducing or releasing pharmaceutical products, e.g. antibiotics, into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30667—Features concerning an interaction with the environment or a particular use of the prosthesis
- A61F2002/3071—Identification means; Administration of patients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2/30771—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
- A61F2002/30795—Blind bores, e.g. of circular cross-section
- A61F2002/308—Blind bores, e.g. of circular cross-section oblong
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2/30771—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
- A61F2002/30878—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves with non-sharp protrusions, for instance contacting the bone for anchoring, e.g. keels, pegs, pins, posts, shanks, stems, struts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2/30771—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
- A61F2002/30878—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves with non-sharp protrusions, for instance contacting the bone for anchoring, e.g. keels, pegs, pins, posts, shanks, stems, struts
- A61F2002/30891—Plurality of protrusions
- A61F2002/30892—Plurality of protrusions parallel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2/30907—Nets or sleeves applied to surface of prostheses or in cement
- A61F2002/30909—Nets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2002/30929—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth having at least two superposed coatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2002/3093—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth for promoting ingrowth of bone tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/3094—Designing or manufacturing processes
- A61F2002/30975—Designing or manufacturing processes made of two halves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/38—Joints for elbows or knees
- A61F2/3859—Femoral components
- A61F2002/3863—Condyles fitted on an anchored base
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/46—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor
- A61F2002/4631—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor the prosthesis being specially adapted for being cemented
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/46—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor
- A61F2002/4632—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor using computer-controlled surgery, e.g. robotic surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/46—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor
- A61F2002/4632—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor using computer-controlled surgery, e.g. robotic surgery
- A61F2002/4633—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor using computer-controlled surgery, e.g. robotic surgery for selection of endoprosthetic joints or for pre-operative planning
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/46—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor
- A61F2/4657—Measuring instruments used for implanting artificial joints
- A61F2002/4658—Measuring instruments used for implanting artificial joints for measuring dimensions, e.g. length
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0014—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
- A61F2210/0019—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol operated at only one temperature whilst inside or touching the human body, e.g. constrained in a non-operative shape during surgery, another temperature only occurring before the operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0033—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements made by longitudinally pushing a protrusion into a complementary-shaped recess, e.g. held by friction fit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0004—Rounded shapes, e.g. with rounded corners
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0004—Rounded shapes, e.g. with rounded corners
- A61F2230/0008—Rounded shapes, e.g. with rounded corners elliptical or oval
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0017—Angular shapes
- A61F2230/0019—Angular shapes rectangular
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2240/00—Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2240/001—Designing or manufacturing processes
- A61F2240/002—Designing or making customized prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/003—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in adsorbability or resorbability, i.e. in adsorption or resorption time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/003—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in adsorbability or resorbability, i.e. in adsorption or resorption time
- A61F2250/0031—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in adsorbability or resorbability, i.e. in adsorption or resorption time made from both resorbable and non-resorbable prosthetic parts, e.g. adjacent parts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0035—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in release or diffusion time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0078—Gender-specific, e.g. different for male and female patients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0085—Identification means; Administration of patients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0085—Identification means; Administration of patients
- A61F2250/0087—Identification means; Administration of patients colour-coded
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0085—Identification means; Administration of patients
- A61F2250/0089—Identification means; Administration of patients coded with symbols, e.g. dots, numbers, letters, words
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00389—The prosthesis being coated or covered with a particular material
- A61F2310/00395—Coating or prosthesis-covering structure made of metals or of alloys
- A61F2310/00419—Other metals
- A61F2310/00544—Coating made of tantalum or Ta-based alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00389—The prosthesis being coated or covered with a particular material
- A61F2310/00592—Coating or prosthesis-covering structure made of ceramics or of ceramic-like compounds
- A61F2310/00796—Coating or prosthesis-covering structure made of a phosphorus-containing compound, e.g. hydroxy(l)apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00389—The prosthesis being coated or covered with a particular material
- A61F2310/0097—Coating or prosthesis-covering structure made of pharmaceutical products, e.g. antibiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J2205/00—General identification or selection means
- A61J2205/20—Colour codes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J2205/00—General identification or selection means
- A61J2205/30—Printed labels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J2205/00—General identification or selection means
- A61J2205/50—General identification or selection means using icons or symbolic figures, e.g. by a graphical representation symbolising the type of pathology or the organ by an image
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J2205/00—General identification or selection means
- A61J2205/60—General identification or selection means using magnetic or electronic identifications, e.g. chips, RFID, electronic tags
Definitions
- the present invention relates to gender specific pharmaceuticals.
- Psychologists may choose different therapeutic techniques to address certain emotional issues with a man than with a woman.
- Personal trainers likewise may employ different physical training regimen for men than for women, and may have different target goals for cardiovascular and muscular development.
- sexual dimorphism is the systematic difference in form between individuals of different gender in the same species. This may include differences in size, color, or the presence of gender defining body parts, such as horns or antlers. While in humans, the male and female forms are perceived differently, they tend to have a low level of sexual dimorphism when compared to other species. For example, the body masses of both male and female humans are approximately normally distributed.
- the notch width at the end of the femur in the knee joint tends to be wider in males than in females.
- medical implants currently are limited to unisex designs. Further examples of differences between men and women may be found in metabolic rates, diurnal changes, range of motion. pH and hormonal changes, elasticity of body tissue, and susceptibility to diseases or medical conditions.
- males and females metabolize medications at different rates and react differently to different types of medications.
- females may metabolize some analgesics and adjuvant drugs at different rates than men, among them oxycodone, tramadol, fentanyl, bupivacaine, and diazepam.
- males may respond more favorably to tricyclic agents and females may get greater relief from selective serotonin reuptake.
- the present invention provides a system and method for accounting for gender specific differences in medical treatment. This is achieved first by taking into account these differences so that a patient's therapy and treatment is more closely tailored to them. This includes, for example, providing gender specific treatment, medical devices, medicines, and/or instrumentation. These differences may result in different techniques being provided for treating bones or joints (such as the knee, hip, or spine), differences in drug selection, drug delivery and dosage, different implant designs, and different treatment for soft tissue repair. These and other non-limiting examples are further discussed in detail below.
- the medical treatment system can include a medical device identification system which differentiates use for male and female patients.
- the medical device identification system includes a container adapted to receive a medical device and a gender specifier.
- the gender specifier is used to identify the gender the medical device is designed for.
- the gender specifier can be incorporated into a label, where the gender specifier can be in text form, symbolic form or color coded. For example, the gender specifier can be in the text form “MALE” or “FEMALE.”
- the gender specifier may also be an electronic device, such as an RFID tag that is associated or packaged with the device or medicine so that it can be readily identified and associated for use with a particular gender.
- This embodiment of the invention may be of particular use for sterilized products, medicines that are sealed in a container, or in other situations where it is difficult to visually confirm for which sex the product is intended.
- the medical treatment system may include a medication container having a gender-specific labeling system.
- the label system may provide information identifying the contents and gender-specific instructions regarding usage of the enclosed medicine.
- the usage information may include, for example, the recommended dosage for one or both genders.
- the gender specifier may be dosage information, but also it may be in a text form, such as “FEMALE” and “MALE,” or alternatively may be in the form of a color coding or in symbolic representations.
- FIG. 1 depicts an exemplary knee joint
- FIG. 2 depicts an exemplary prosthetic knee joint
- FIG. 3 depicts an exemplary femoral component of a male prosthetic knee joint
- FIG. 4 depicts an exemplary tibial component of a male prosthetic knee joint
- FIG. 5 depicts an exemplary femoral component of a female prosthetic knee joint
- FIG. 6 depicts an exemplary tibial component of a female prosthetic knee joint
- FIG. 7 depicts an another exemplary femoral component of a prosthetic knee joint
- FIG. 8 depicts an exemplary rotatable tibial component of a prosthetic knee joint
- FIG. 9 depicts a partial cross section of the rotatable tibial component of FIG. 8 :
- FIG. 10 depicts a platform of a rotatable tibial component of a prosthetic knee joint
- FIG. 11 depicts a platform of a rotatable/translatable tibial component of a prosthetic knee joint
- FIG. 12 depicts another platform of a rotatable/translatable tibial component of a prosthetic knee joint
- FIG. 13 depicts an exemplary male patella with pegs or contact points arranged based on the male anatomy
- FIG. 14 depicts an exemplary female patella with pegs or contact points arranged based on the female anatomy
- FIG. 15 depicts an exemplary bi-compartmental femoral component of a male prosthetic knee joint
- FIG. 16 depicts an exemplary bi-compartmental femoral component of a female prosthetic knee joint
- FIG. 17 depicts a schematic diagram of a computer navigation system of the present invention.
- FIG. 18 depicts a triangular mapping of a femur portion of a knee joint
- FIG. 19 depicts a triangular mapping of a tibia portion of a knee joint
- FIG. 20 depicts an exemplary vascular stent
- FIG. 21 depicts an exemplary female vascular stent
- FIG. 22 depicts a cross sectional view of an embodiment of the stent of FIG. 20 ;
- FIG. 23 depicts an exemplary medical implant including an energy sink:
- FIG. 24 depicts a representative packaging material of the present invention
- FIG. 25 depicts a representative label affixed to the packaging material of FIG. 24 ;
- FIG. 26 depicts a representative medicine container of the present invention
- the present invention provides a system and method for gender specific medical treatment. As mentioned above, gender differences are often ignored when determining how to treat a medical condition. It is believed that accounting for one or more of these differences during treatment may greatly improve the quality of care and degree of recovery that a patient experiences.
- Knee replacements are about twice as likely to be performed on women as on men. There are gender-specific differences in the bones and joint associated with the knee that are not currently taken into account in this area of medicine. For example, the female patella is generally thinner and narrower in superior and inferior dimensions, while in men it is generally wider in proportion.
- FIG. 1 there is shown an anterior view of a knee joint 10 , wherein the patella is not shown.
- the knee joint 10 includes a femoral portion 12 having medial and lateral condyles 14 and 16 .
- a trochlear groove 18 is interposed between the medial and lateral condyles 14 and 16 , allowing for tracking of the patella along the end portion of the femur 12 as the knee joint 10 is flexed and extended.
- a tibial portion 20 of the knee joint 10 includes a tibial plateau 22 , including medial and lateral menisci 24 and 26 disposed on the tibial plateau 22 .
- the medial and lateral condyles 14 and 16 abut the tibial plateau 22 , engaging the medial and lateral menisci 24 and 26 allow for rotation of the tibia 20 with respect to the femur 12 and shock absorption between the femur 12 and tibia 20 .
- a central longitudinal axis of the femur portion 12 is aligned at an angle a with respect to a central longitudinal axis of the tibial portion 20 .
- an exemplary prosthetic knee 28 includes a femoral component 30 and a tibial component 32 .
- the femoral component 30 is configured to curve about the cut end portions of the medial and lateral condyles 14 and 16 , having a trochlear groove 34 therein to allow tracking of the patella about the femoral component 30 as the knee joint 10 is flexed and extended.
- the tibial component 32 includes flat platform 36 with a cushioning material 38 , replacing the medial and lateral meniscus 24 and 26 .
- the femoral and tibial components 30 and 32 cooperate to permit normal knee-joint functioning.
- the femoral and tibial components 30 and 32 are designed similar in size and shape to average knee joints, and have a range of sizes to span the normal size ranges of the knee joints.
- one aspect of the present invention is directed to a prosthetic knee joint that is configured and dimensioned for gender specific use.
- the prosthetic knee joint may have a reduced bearing surface, such as being reduced by 10 percent or more in comparison to a male prosthetic knee design.
- the reduced bearing surface would allow greater range of motion of the implant corresponding to the greater range of motion typically exhibited in women.
- the implant for women may also be significantly thinner, such as being at least 5 percent thinner, at least 10 percent thinner, or alternatively at least 20 percent thinner than implants for men.
- a formal prosthetic knee for women may also have one or more of the following: thinner runners to help improve range of motion, lesser amount of metal, or greater flexibility.
- the present invention also contemplates female specific and male specific bone cement, with the composition of the female bone cement differing from the male bone cement.
- fillers could be added to the PMMA (the principal component of the bone cement) to change the mechanical properties.
- other components such as an antibiotic
- a female bone cement may have added components to address the osteoporotic bone found in women.
- Such components include calcium supplements and other agents for promoting an osteogenic or osteoconductive effect (or slowing the process of bone demineralization).
- a male femoral component 40 of a knee joint implant of the present invention is provided.
- the femoral component 40 includes medial and lateral condyle portions 42 and 44 each having a width W 1 and a radius R 1 .
- a trochlear groove 46 is disposed between the medial and lateral condyle portions 42 and 44 and has a width W2.
- the widths W1 and W2 and the radius R1 of the femoral components 40 are provided in a range of sizes to span the normal size ranges of male human knee joints. Additionally, the thickness t 1 and the material densities of the femoral components 40 are selected to correspond to male bone thickness and densities.
- a male tibial component 48 of a knee joint of the present invention is provided.
- the tibial component 48 includes flat platform 50 , having a substantially oval shape, wherein the cushioning material 52 replaces the medial and lateral meniscus 24 and 26 .
- a bone spike 54 is included for insertion into the prepared end of the tibia, securing the tibial component 48 to the tibia.
- the bone spike 54 can be substantially conical in shape, having a maximum diameter d 1 and length l 1 .
- a female femoral component 60 of a knee joint implant of the present invention is provided.
- the femoral component 60 includes medial and lateral condyle portions 62 and 64 each having a width W 3 and a radius R 2 .
- a trochlear groove 66 is disposed between the medial and lateral condyle portions 62 and 64 and has a width W 4 .
- the widths W 3 and W 4 and the radius R 2 of the femoral components 60 are provided in a range of sizes to span the normal size ranges of female human knee joints. Additionally, the thickness t 2 and the material densities of the femoral components 60 are selected to correspond to female bone thickness and densities.
- female tibial component 70 of a knee joint of the present invention is provided.
- the tibial component 70 includes flat platform 72 , having a substantially elongated oval shape, wherein the cushioning material 74 replaces the medial and lateral meniscus 24 and 26 .
- a bone spike 76 is included for insertion into the prepared end of the tibia, securing the tibial component 70 to the tibia.
- the bone spike 74 can be substantially conical in shape, having a maximum diameter d 2 and length h.
- the male femoral component 40 will generally have greater widths W 1 and W 2 and the radius R 1 , thus bearing surface area, than that of comparable female femoral component 60 widths W 3 and W 4 and the radius R 2 .
- the male femoral component 40 will generally have a greater material thickness t 1 than that of thickness t 2 of a comparable female femoral component 60 .
- a “large” size for a male prosthetic knee joint may differ significantly in size, proportion, and construction from a large-sized prosthetic knee joint for women. Furthermore, as shown in FIG.
- an upper section 68 of the female femoral component 60 can be generally narrower than that of a comparably male femoral component 40 , to accommodate structural differences between the female and male femurs.
- the female femoral component 60 design can have scalloped edges compared to the male femoral component 40 design.
- the thickness, the material densities, and the material composition of the femoral components 40 and 60 may be selected to correspond to different male and female bone thickness and densities. Additional dimensions of the femoral portion of the knee joint can be utilized in the design and configuration of the femoral components 40 and 60 .
- the tibial components 58 and 70 are designed and configured for use in replacement of the knee joint in males and females.
- the dimensions of the tibial components once again may be provided in a range of sizes to span the normal size ranges of male and female human knee joints.
- the male platform 50 has a substantially oval shape
- the female platform 72 has an elongated oval shape.
- the shapes of the platforms 50 and 72 are selected to accommodate the differences in sizes and bearing surface areas of the corresponding male and female femoral components 48 and 60 .
- the thickness and the material densities of the tibial components are selected to correspond to or function with male and female bone thickness, densities, geometry, range of motion, or the like. Furthermore, additional dimensions of the tibial portion of the knee joint can be utilized in the design and configuration of the tibial components 48 and 70 .
- a gender-specific design may be identified by one component having less material than for the opposite sex.
- additional dimensions of the femoral portion of the knee joint can be utilized in the design and configuration of the femoral components. One or more of these dimensions may be varied so that an implant is more suited to a male or female patient.
- an implant design may be considered gender-specific if one or more of these parameters has been selected to better match either a male or female.
- a gender-specific prosthetic design may also be identified by comparing relative differences that exist between a female design and a male design. For example, if one or more dimensions (e.g., bearing surface area, widths, radii, curvature, thickness of material, amount of metal, range of motion, flexibility, etc.) or relative proportions (e.g., relative width or relative differences in angles, minimum or maximum sizes, etc.) or an implant design for one sex varies by more than 5 percent, or alternatively by 10 percent or more, or even by about 20 percent or more, from an implant designed for the opposite sex, then the design may qualify as being gender-specific.
- dimensions e.g., bearing surface area, widths, radii, curvature, thickness of material, amount of metal, range of motion, flexibility, etc.
- relative proportions e.g., relative width or relative differences in angles, minimum or maximum sizes, etc.
- the femoral component 80 includes medial and lateral condyle portions 82 and 84 .
- the medial condyle portion 82 has a width Wm and a radius R m and the lateral condyle portion 84 has a width W L and a radius R L , wherein the width W m and W L can be of equal dimension, or in the alternative, the widths W m and W L can be of non-equal dimension.
- the medial and lateral condyle portions 82 and 84 radii R m and R L can be of equal dimension, or in the alternative, radii R m and R L can be of non-equal dimension.
- the size differences between the widths and/or radii of the medial and lateral condyle portions can be at least 5 percent, 10 percent, or 20 percent.
- a trochlear groove 86 is disposed between the medial and lateral condyle portions 82 and 84 and has a width W 1 .
- the widths W m and W L and the radii R m and R L of the femoral components 80 can be provided in a range of sizes to more precisely emulate the size and dimensions of a male or female human knee joints.
- the radii R m and R L of the medial and lateral portions 82 and 84 of the femoral component 80 can be selected such that the radius Rm of the medial condyle portion is larger with respect to the radius R L of the lateral condyle portion.
- the radii R m and R L of the medial and lateral portions 82 and 84 form a substantially partial conical surface.
- the thickness 3 and the material densities of the femoral components 80 are selected to correspond to male or female bone thickness and densities.
- a male femoral component will generally have greater widths W m and W L and the radii R m and R L , thus bearing surface areas, than that of a comparable female femoral component widths W m and W L and the radii R m and R L .
- the male femoral component will generally have a greater material thickness t3 than that of thickness of a comparable female femoral component.
- a “large” size for a male prosthetic knee joint may differ significantly in size, proportion, and construction from a large-sized prosthetic knee joint for women. Furthermore, as shown in FIG.
- an upper section of the female femoral component can be generally narrower than that of a comparably sized male femoral component to accommodate structural differences between the female and male femurs.
- a female femoral component design can have scalloped edges compared to the male femoral component design.
- the thickness, the material densities, and the material composition of the femoral components may be selected to correspond to different male and female bone thickness and densities. Additional dimensions of the femoral portion of the knee joint can be utilized in the design and configuration of the femoral components.
- a tibial component 90 of a knee joint of the present invention is provided.
- the tibial component 90 includes a platform 92 , having a substantially oval shape, wherein a cushioning material 94 replaces the medial and lateral meniscus 24 and 26 .
- a bone spike 96 is included for insertion into the prepared end of the tibia, securing the tibial component 90 to the tibia.
- the bone spike 96 can be substantially conical in shape, having a maximum diameter d 1 and length l 1 .
- the platform 92 can be rotatably connected to the bone spike 96 , such that the platform 92 can rotated with respect to the central longitudinal axis “A” of the bone spike 96 .
- the platform 92 includes a slotted section 98 , in which a head portion 100 of the bone spike 96 is positioned.
- the slotted section 98 is configured to capture the head portion 100 of the bone spike 96 , securing the head portion 100 within the slotted section 98 , yet allowing the platform 92 to rotate with respect with the bone spike 96 .
- the platform 92 can rotate with respect to a femoral component as the knee joint is moved between flexion and extension, thereby decreasing the frictional forces between the contacting surfaces of the femoral component and a cushioning material of the platform 92 .
- the rotation of the platform 92 can decrease the stresses provided on the implant/bone interface, decreasing the likelihood of failure and increasing the life expectancy of the implant. It is contemplated that the other rotational, translation, and positional configurations of the platform 92 with respect to the bone spike 96 can be provided to further increase the efficiency of emulating a natural knee joint and accounting for the anatomical differences between male and female joints.
- the bone spike 96 can be centrally positioned on the flat platform 92 , such that the center 102 of the platform 92 is aligned along the central longitudinal axis of the bone spike 96 .
- the bone spike 96 ′ can be positioned offset from the center 102 of the platform 92 , such that the center 102 of the platform 92 is rotatable about the bone spike 96 ′.
- the platform 92 can include an elongated slotted section 104 , such that the platform 92 can slide in the anterior and posterior directions as the knee joint is moved between flexion and extension.
- the platform 92 can rotate with respect to the bone spike 96 as the knee joint is moved between flexion and extension. In this manner, the compound movement for the platform 92 can be used to emulate high flexion.
- the platform 92 includes an angular elongated slotted section 106 , such that the platform 92 can slide substantially in the anterior/posterior and medial/lateral directions as the knee joint is moved between flexion and extension.
- the platform 92 can rotate with respect to the bone spike 96 as the knee joint is moved between flexion and extension.
- the tibial components 90 are designed and configured for use in replacement of the knee joint in males and females.
- the dimensions of the tibial components once again may be provided in a range of sizes to span the normal size ranges of male and female human knee joints.
- the male platform 50 has a substantially oval shape
- the female platform 72 has an elongated oval shape.
- the shapes of the platforms 50 and 72 are selected to accommodate the differences in sizes and bearing surface areas of the corresponding male and female femoral components 48 and 60 .
- the thickness and the material densities of the tibial components are selected to correspond to or function with male and female bone thickness, densities, geometry, range of motion, or the like.
- additional dimensions of the tibial portion of the knee joint can be utilized in the design and configuration of the tibial component 90 .
- a male patella 110 and a female patella 112 are provided. As shown in these figures, the male and female patellas 110 and 112 have substantially different shapes, where the female patella 112 is more elongated with respect to the male patella 110 . As such, when replacement patellas are provided, they are provided in accordance with the gender of the patient.
- contact pegs 114 can be affixed to the surface, providing multiple point contact surfaces between the patella and the femur or femoral implant.
- the arrangement of the pegs 114 can be changed accordingly.
- the pegs 114 are positioned in a substantially triangular configuration for the male patella, allowing for the wider surface of the male patella 110 .
- the pegs 114 are positioned in a substantially linear configuration, allowing for the more linear surface of the female patella 114 .
- FIGS. 2-14 show total knee replacement components
- the present invention is well-suited for partial knee replacement components such as uni-compartmental and bi-compartmental implants.
- the present invention also contemplates the use for re-surfacing and surface bearing procedures and/or components.
- a bi-compartmental male femoral component 120 of a knee joint implant of the present invention includes medial and lateral components 122 and 124 .
- the medial component 122 includes a medial condyle portion 126 having a width W m and a radius R m .
- the lateral component 124 includes a lateral condyle portion 128 having a width W L and a radius R L .
- the widths W m and W L can be of equal dimension or can be of different dimensions.
- the medial and lateral condyle portions 126 and 128 radii R m and R L can be of equal dimension or can be of non-equal dimension.
- a trochlear groove 130 formed by the combination of the medial and lateral components 122 and 124 is disposed between the medial and lateral condyle portions 126 and 128 and has a width W 1 .
- a bi-compartmental female femoral component 140 of a knee joint implant of the present invention is provided.
- the femoral component 140 includes medial and lateral components 142 and 144 .
- the medial component 142 includes a medial condyle portion 146 having a width Wm and a radius R m .
- the lateral component 144 includes a lateral condyle portion 148 having a width W L and a radius R L .
- the widths W m and W L can be of equal dimension or can be of different dimensions.
- the medial and lateral condyle portions 146 and 148 radii R m and R L can be of equal dimension or can be of different dimensions.
- a trochlear groove 150 formed by the combination of the medial and lateral components 142 and 144 is disposed between the medial and lateral condyle portions 146 and 148 and has a width W 1 .
- the widths W m and W L and the radii R m and R L of the medial and lateral components 132 and 134 are provided in a range of sizes to span the normal size ranges of female human knee joints. Additionally, the thickness t2 and the material densities of the medial and lateral components 132 and 134 are selected to correspond to female bone thickness and densities.
- male femoral components will generally have greater widths W m and W L and radii R m and R L , thus bearing surface area, than that of comparable female femoral components widths W m and W L and radii R m and R L .
- the male femoral components will generally have a greater material thickness t 1 than that of thickness of a comparable female femoral component.
- a “large” size for a male prosthetic knee joint may differ significantly in size, proportion, and construction from a large-sized prosthetic knee joint for women. Furthermore, as shown in FIGS.
- an upper section 152 of the female femoral components 142 and 144 can be generally narrower than that of a comparably male femoral components 122 and 124 , to accommodate structural differences between the female and male femurs.
- the upper section 152 is such that the female femoral components 142 and 144 have scalloped edges compared to the male femoral components 122 and 124 .
- the thickness, the material densities, and the material composition of the femoral components 122 , 124 , 142 , and 144 may be selected to correspond to different male and female bone thickness and densities. Additional dimensions of the femoral portion of the knee joint can be utilized in the design and configuration of the femoral components 142 and 144 .
- a gender-specific design may be identified by one component having less material than for the opposite sex.
- additional dimensions of the femoral portion of the knee joint can be utilized in the design and configuration of the femoral components. One or more of these dimensions may be varied so that an implant is better suited to a male or female patient.
- an implant design may be considered gender-specific if one or more of these parameters has been selected to better match either a male or female.
- a gender-specific prosthetic design may also be identified by comparing relative differences that exist between a female design and a male design. For example, if one or more dimensions (e.g., bearing surface area, widths, radii, curvature, thickness of material, amount of metal, range of motion, flexibility, etc.) or relative proportions (e.g., relative width or relative differences in angles, minimum or maximum sizes, etc.) or an implant design for one sex varies by more than 5 percent, or alternatively by 10 percent or more, or even by about 20 percent or more, from an implant designed for the opposite sex, then the design may qualify as being gender-specific.
- dimensions e.g., bearing surface area, widths, radii, curvature, thickness of material, amount of metal, range of motion, flexibility, etc.
- relative proportions e.g., relative width or relative differences in angles, minimum or maximum sizes, etc.
- the computer navigation system 160 includes a central processing unit (CPU) 162 , having a processor 164 and memory 166 , a display device 168 , and input devices, including a keyboard 170 and a stylus 172 .
- a computer program is stored on the CPU 162 , where the computer program can be used to aid in the selection, preparation, and insertion of implants into a patient.
- the stylus 172 can be used to provide single point locations or multiple point locations to outline the contours of a surface of a portion of a joint.
- the navigation system 160 can further include a printer 174 .
- An anatomical database is stored on the CPU 162 and is accessible by the computer program to determine appropriate implants for use in the patient.
- the anatomical database includes information relating to a joint in the body of a patient, for example a knee joint.
- the anatomical database includes a library of joint mappings, having a broad range of joint sizes, as well as including information relating to gender differences in the joints.
- the anatomical database can include information on bone thickness, density, the radii of the medial and lateral condyles, the widths of the medial and lateral condyles, the width of the trochlear groove, and the angular relationship of the medial and lateral condyles with respect to the central longitudinal axis of the femur for a broad range of different size joints for male and females.
- conventional computer navigation systems include a library or database of anatomical parameters that are used in the registration or other calibrating process, but the anatomical parameters are based on a unisex model that represents a composite of male and female anatomies.
- the computer navigation system of the present invention includes a male library or database and a female library or database.
- the separate libraries or databases include differences in the anatomy. Exemplary differences have been discussed previously and additional gender differences are described below. Thus, with the computer navigation system of the present invention, the patient's gender is selected and the appropriate library or database is used in the registration or other calibrating process.
- the stylus 172 is used to the map the joint, with at least three points located on the joint to determine the anatomical parameters of the joint.
- the joint mapping is displayed on the display device 168 .
- the stylus 172 maps the femoral portion 12 of the knee joint 10 .
- the stylus 172 is used to locate a home point “HP” on the femur 12 , where the home point lies on the top surface on the femur 10 in a plane defined by the central longitudinal axis “A” of the femur 10 .
- At least two additional points “P 1 ” and “P 2 ” are located with respect to the home point, such as end surfaces of the medial and lateral condyles 14 and 16 .
- the three points (HP, P 1 and P 2 ) define a triangular mapping “T 1 ” of the femoral portion 12 of the knee joint 10 , which is displayed on the display device 168 .
- gender information is also provided.
- the display device 168 displays a generic knee joint, highlighting a point on the joint to be located using the stylus 172 .
- a home point “HP” and the end surfaces of the medial and lateral condyles are highlighted on the generic knee joint.
- the stylus 172 is utilized to locate the corresponding points on the knee joint 10 of the patient.
- the computer program utilizes the mapped points and the gender information to provide a preliminary model for the femoral portion 12 , which is displayed on the display device 168 .
- the preliminary model is based on a statistical analyzing of the relationship of the mapped points and the gender information, in comparison to the knee joint database.
- the resulting preliminary model can include information on the radii of the medial and lateral condyles, the widths of the medial and lateral condyles, the width of the trochlear groove, and the angular relationship of the medial and lateral condyles with respect to the central longitudinal axis of the femur.
- Based on the preliminary model an appropriately size femoral implant can be selected for use, as well as a corresponding cutting pattern for that implant.
- the input device 170 can be used to map anterior and posterior points of the medial and lateral condyles, the femoral contacting surface of the medial and lateral condyles, the trochlear groove, etc. Additional information, such as the bone diameter and angular relationship between the femur and the pelvis can be utilized to refine the model.
- the computer navigation system 160 can be used to map the tibial portion 20 of the knee joint 10 .
- the stylus 172 is used to locate reference points on the end portion of the tibia 20 with respect to the home point “HP” on the femur 12 .
- the stylus 172 can be used to map points along the tibial plateau 22 , including the tibial plateau end points P 3 and P 4 , to providing a triangular model “T 2 ” of the tibia 20 as well as the angular relationship “a” between the tibia 20 and femur 12 .
- the computer program utilizes the mapped points and the gender information to provide a preliminary model for the tibial portion 20 , which is displayed on the display device 168 .
- the tibial portion 20 can be displayed either individually or in relation to the femoral portion 12 .
- the resulting preliminary model can be used to select an appropriately sized tibial implant, as well as a corresponding cutting pattern for that implant.
- the selection of the femoral and tibial implants is not only based on the inputted data, by also on the implants themselves, and their ability to function appropriately together.
- a medical implant such as a prosthetic knee for men or women.
- surfaces of the device may have different ingrowth surfaces, porosity. HA, or BMP coated or bonded to it.
- additional prosthetic implants can be designed and configured for gender specific use.
- the female pelvis is distinguished from that of the male by its bones being more delicate and shallower in depth.
- the ilia of the female pelvis are less sloped, and the anterior iliac spines more widely separated; hence the greater lateral prominence of the hips in females.
- the superior aperture of the lesser pelvis is larger in the female than in the male; it is more nearly circular, and its obliquity is greater.
- the inferior aperture is larger and the coccyx more movable.
- the sciatic notches are wider and shallower, and the spines of the ischia project less inward.
- the ischial tuberosities and the acetabula are wider apart, and the former are more everted.
- the pubic symphysis is less deep, and the pubic arch is wider and more rounded than in the male, where it is an angle rather than an arch.
- prosthetic hip implants may be designed and configured for gender specific use, taking into account the structural differences between the female and male pelvis and connecting femurs.
- an implant designed for women may be designed to provide greater range of motion than a similar implant designed for men.
- Females often benefit from having a greater range of motion for hips just as they do for knees.
- the female design may be more flexible in the acetabular component, more flexible in the femoral stem, or have a greater modulus of elasticity (especially in more osteoporotic bone). Designing the female prosthetic so that the femoral head contacts a thinner acetabulum also may change range of motion and stability to be more suitable for women than men.
- the offset for the femoral head and neck region may be different for men than women.
- a female design may have less offset while a male design may have a greater offset to increase the lever arm.
- the difference in offset may be about 5 percent or greater in one embodiment, although as described above the offset may differ by 10 percent or more, or by 20 percent or more.
- prosthetic designs such as the hip may incorporate gender-specific features is with the use of different ingrowth surfaces.
- the superior portion under compression on the acetabular component may have HA coating and/or a roughened surface texture for one gender while less or no HA coating and/or a smoother surface texture for the opposite gender.
- the inferior coating may be porous or fiber metal coating or porous tantalum coating so that there would be two or more ingrowth surfaces on the same gender-specific implant.
- one or more components may be color-coded so that they may be more readily identified by visual inspection.
- the rotating or bearing surface of the femoral head may have one color for women and another color for men.
- a component having a pink visible surface may signify that the gender-specific design of the implant is for women, while a black surface may signify that the gender-specific design is for men.
- This color-coding of one or more components may be used in place of or in conjunction with any other gender identification systems, including those described elsewhere herein.
- gender specific prosthetic implants can be designed and configured for use in the any joint in a body, including ankle, knee, hip, spine, neck, wrist, elbow, and shoulder.
- a nucleus pulposes implant for women may have greater elasticity or greater hydrophilic capability.
- the shape, angle, or distance distracted between the disc space may be designed to be gender-specific for men and women.
- disc replacement technology may have gender-specific features such as differences in disc height or angulation changes such as lordosis or rotational angle.
- a spinal cage could have gender-specific designs that vary in thickness or forced expansion.
- Bone cement such as used in spine treatment or in treating other bones in the body, also may have a different viscosity for men and women, different rates of introduction into the body, or different amounts of bonding or interdigitation, especially with osteoporotic bone in females versus males.
- gender-specific designs also may result in kits of implants, tools and devices tailored primarily for a particular gender. For instance, a kit of implants of varying sizes intended for women may have a generally smaller size than a kit of similar implants intended for men. Providing a gender-specific kit allows for the reduction or elimination of conventional kit components that might primarily be intended for use on the opposite sex. Likewise, there may be differences in the tools and instruments provided in one kit versus another due to anatomical, physiological, or other differences between men and women. One benefit of providing gender-specific kits is that it may reduce the amount of variety of devices and instruments that may be prepared for a particular surgery. The potential reduction in complexity and number of devices and instrumentation may in turn allow a physician to perform surgeries more efficiently and successfully.
- Sutures also may be designed to have gender-specific features.
- suture materials are all designed to have the same properties for men and women. Under the present invention, however, suture material may have greater elasticity for females than for males.
- Stents are another example where a currently unisex approach could be improved by taking into account gender-specific differences. Stents are used in a wide variety of applications, such as for aneurysms, aortic, cardiac, carotid, vascular anastomosis, vascular angioplasty, and the like. As is well known stents are typically inserted in a compressed state and then expanded when in position. The expansion of stents today is the same for men and women; yet female vessel tissue tends to be more elastic than in men. Therefore, it is believed the vessels in women would apply a less resistance to an opening stent than in men.
- one embodiment of the present invention would be to design a stent to require a lower opening force for women than a stent designed for men.
- a balloon used to expand a male designed stent may apply a greater opening force than a balloon used to expand a female designed stent.
- stent expansion may involve less elasticity and greater stiffness in men than in women since male vessel tissue is generally more rigid than for women. Since female tissue often is more pliable, a female stent design may have a lower modulus of elasticity to expand, may be more elastic, and less rigid.
- a male stent design may have differences in drug release than in women. For example, a male stent design may have a greater drug release associated with it, may have specific localized drug release, or a greater concentration of drug released over a shorter period. Additionally, different drug combinations may be associated with a male stent design than for a female stent design. The stent may have multiple layers for providing different drug deliveries for men and women.
- one layer may be porous or permeable that allows a drug to be released from an inner coating or layer.
- the porous or permeable coating or layer may have different apertures for men than for women, thereby providing a gender-specific drug delivery.
- the coatings or layers may react differently to temperature, pH, or other differences in the intended environment that may be present between men and women.
- a porous or permeable layer may have an outer coating that dissolves when deployed in a female, thereby allowing the inner coating or layer to be released into the body, but remains substantially intact during exposure in a male body.
- the outer coating may have a different rate of degradation for men than women, thereby allowing for gender-specific rates of drug delivery.
- FIG. 20 illustrates an embodiment of the invention concerning an arterial stent 180 .
- Stents are particularly useful in the treatment and repair of blood vessels after a stenosis has been compressed by percutaneous transluminal coronary angioplasty (PTCA), percutaneous transluminal angioplasty (PTA), or removed by atherectomy or other means, to help improve the results of the procedure and reduce the possibility of restenosis.
- Stents also can be used to provide primary compression to a stenosis in cases in which no initial PTCA or PTA procedure is performed.
- stents are most often used in the procedures mentioned above, they also can be implanted on another body lumen such as the carotid arteries, peripheral vessels, urethra, esophagus and bile duct.
- a guiding catheter or sheath is percutaneously introduced into the cardiovascular system of a patient through the femoral arteries and advanced through the vasculature until the distal end of the guiding catheter is in the aorta.
- a guidewire and a dilatation catheter having a balloon on the distal end are introduced through the guiding catheter with the dilatation catheter sliding over the guidewire.
- the guidewire is first advanced out of the guiding catheter into the patient's vasculature and is directed across the arterial lesion.
- the dilatation catheter is subsequently advanced over the previously advanced guidewire until the dilatation balloon is properly positioned across the arterial lesion.
- the expandable balloon is inflated to a predetermined size, such as with a radiopaque liquid, at relatively high pressure to displace the atherosclerotic plaque of the lesion against the inside of the artery wall and thereby dilate the lumen of the artery.
- the balloon is then deflated to a small profile so that the dilatation catheter can be withdrawn from the patient's vasculature and the blood flow resumed through the dilated artery.
- a predetermined size such as with a radiopaque liquid
- angioplasty procedures of the kind referenced above, abrupt reclosure may occur or restenosis of the artery may develop over time, which may require another angioplasty procedure, a surgical bypass operation, or some other method of repairing or strengthening the area.
- a physician can implant an intravascular prosthesis for maintaining vascular patency, commonly known as a stent, inside the artery across the lesion.
- Stents are generally cylindrically shaped devices which function to hold open and sometimes expand a segment of a blood vessel or other arterial lumen, such as a coronary artery.
- Stents are delivered in a radially compressed condition to the target location and then are deployed into an expanded condition to support the vessel and help maintain it in an open position.
- the stent may be a self-expanding type formed from, for example, shape memory metals or super-elastic nickel-titanium (NiTi) alloys, which will automatically expand from a compressed state when the stent is advanced out of the distal end of the delivery catheter into the body lumen.
- the invention provides stents 180 that are configured and dimensioned for gender specific use. As noted above, upon insertion into an artery, the stent 180 expands from an initial, compact condition to an expanded condition having a diameter D 1 , wherein the rate of expansion E is dependent on the material properties of the stent 180 . In the expanded condition, the diameter D 1 is of sufficient size to impart an expansive force Fe onto the inner arterial wall.
- the stent 180 is designed and configured for use in angioplasty procedures in males.
- One or more stents 180 may be provided having at least one rate of expansion E and at least one expanded diameter D 1 configured and dimensioned to span the normal size ranges of male human arteries.
- the expansive force Fe imparted onto the inner arterial wall is a function of the arterial wall thickness, such that the expansive force Fe is of sufficient strength to maintain the artery in an open condition preventing reclosure, without damage to the inner arterial wall.
- additional dimensions of the arteries can be utilized in the design and configuration of the stent 180 .
- the stent 182 is designed and configured for use in angioplasty procedures in females.
- one or more stents 182 may be provided having at least one rate of expansion E and at least one expanded diameter D2 configured and dimensioned to span the normal size ranges of female human arteries.
- the expansive force Fe imparted onto the inner arterial wall is a function of the arterial wall thickness, such that the expansive force is of sufficient strength to maintain the artery in an open condition preventing reclosure, without damage to the inner arterial wall.
- additional dimensions, gender-specific features, or other parameters of the arteries can be utilized in the designed and configuration of the gender specific stent 182 .
- the stent 82 also may account for the effect of an illness or medical condition on the strength, size, or thickness of a vessel or vessel wall, which optionally may also be dependent at least in part upon gender.
- Some of the structural features of the stents that account for gender-specific differences include the following: stent 182 has ends that flare outwardly, while stent 80 is substantially cylindrical; stent 182 has fewer openings than stent 180 ; and the openings in the sidewall of stent 182 are generally larger than the openings in the sidewall of stent 180 .
- coatings can be used to make stent designs gender specific. It is well known that the stents 180 and 182 can be coated with a pharmaceutical agent 184 . As shown in FIG. 22 , the pharmaceutical agent 184 can be combined with a coating 186 or other medium used for controlled release rates of the pharmaceutical agent 184 . The pharmaceutical agent 184 can be incorporated into or covered by a monolithic layer or coating, wherein the agent 184 diffuses through the coating 186 and is released into the surrounding fluid. Alternatively, the coating 186 can be a degradable coating, such that as the coating 186 degrades the pharmaceutical agent 184 is released.
- the pharmaceutical agent 184 can be a drug used for the prevention or treatment of restenosis.
- Formulations useful for restenosis prevention or treatment can include, but ar not limited to, heparin and heparin fragments, colchicine, taxol, agiotensin converting enzyme (ACE) inhibitors, angiopeptin, Cyclosporin A, goat-anti-rabbit PDGF antibody, terbinafine, trapidil, interferon-gamma, steroids, ionizing radiation, fusion toxins, antisense oligonucleotides, gene vectors, and rapamycin.
- ACE agiotensin converting enzyme
- the pharmaceutical agent 184 may be a therapeutic biologic agent.
- agents include, but am not limited to, hormones, cells, fetal cells, stem cells, bone morphogenic proteins (BMPs), tissue inductive factors, enzymes, proteins, RNA, viruses, etc.
- one embodiment of the invention provides a coated stents 180 , 182 where the coating is formulated differently for different genders.
- the pharmaceutical agent 184 release rate and dosage are selected to correspond to expected male metabolization and reactions.
- a coating 186 may also be provided on the stent 180 , 182 so that the pharmaceutical agent 184 is covered by or incorporated into the coating 186 .
- the coating 186 may be used to control the timing and release rate of the pharmaceutical agent 184 .
- the pharmaceutical agent 184 may be released gradually through diffusion through the coating 184 or after at least partial degradation of the coating 186 .
- the coating 186 can be designed and configured to release the pharmaceutical agent 184 at a rate and dosage corresponding to metabolization and potential reactions of primarily either men or women.
- the pharmaceutical agent 184 release rate and dosage may be selected to correspond to expected female metabolization and reactions in the same manner.
- stent 180 , 182 was depicted, in other embodiments, similar techniques may be used to coat other types of implantable medical devices, such as hip and knee replacements (total and partial), spinal implants, scaffolds, biological implants or grafts, tissue grafts, screws, plates, rods, prosthetic devices, etc.
- a gender-specific design may also involve altering or controlling the treated area differently for men than for women.
- a medical implant in the form of a prosthetic knee joint 190 including a femoral and tibial component 192 and 194 .
- the femoral component 192 is configured to provide a localized environmental change in a body of a patient.
- a localized increase in temperature can have beneficial effects, which include (but are not limited to): aiding in the alleviation of localized pain, fighting of local infections, and increasing vascular flow and permeability of vessels at the treatment site to control delivery of pharmaceutical agent.
- a localized increasing in temperature increases the permeability of the local tissue, allowing for an increased and more efficient absorption of the pharmaceutical agent into the treatment site.
- the femoral component 192 includes an energy sink 196 , wherein the energy sink 196 can be used to control the localized temperature of the surrounding tissue.
- the energy sink 196 can be a heat sink, wherein the heat sink 196 is charged by an internal or external energy unit 198 .
- the heat sink 196 produces a local increase in temperature.
- the male and female genders react differently to localized changes in temperatures. For example, a localized increase in temperature of B degrees may have beneficial effect on a female, but no effect on a male.
- the applied energy is gender dependent. For example, in a female X amount of energy may be required to heat the heat sink 196 to sufficiently raise the localize temperature to have a beneficial effect.
- Y amount of energy may be required to heat the heat sink 196 to sufficiently raise the localize temperature to have a beneficial effect, wherein Y is greater than X.
- the applied energy and heat sink of a femoral component 192 are designed and configured for gender specific use, taking into account the reactive differences between the female and male genders.
- a localized change in pH can have similar beneficial effects, which include (but are not limited to): aiding in the alleviation of localized pain, fighting of local infections, and increasing vascular flow and permeability of vessels at the treatment site to control delivery of pharmaceutical agent.
- a localized increase in pH may increase the permeability of the local tissue, thereby allowing for an increased and more efficient absorption of the pharmaceutical agent into the treatment site.
- the energy sink 196 in the femoral component 192 can be a pH sink 196 .
- the pH sink 196 can be incorporated into the femoral component 192 or be positioned separate from the femoral component 192 . Therefore, the pH sink 196 may be configured to release a chemical to produce either an increase or decrease in the local pH in order to provide a more gender-specific use.
- An acidic agent would lower the pH and a basic agent would raise the pH. Such agents are well-known to those of ordinary skill.
- the male and female genders react differently to localized changes in pH.
- a localized increase or decrease in the acidity of the surrounding tissue may have a beneficial effect on a female, but no effect on a male.
- the chemical and release rate thereof is dependent on the gender of the patient.
- the pH sink 196 is designed and configured for gender specific use, taking into account the reactive differences between the female and male genders.
- temperature or pH changes may also be used to induce the release of beneficial enzymes, proteins, hormones, etc. from the cells in the treatment site.
- beneficial enzymes, proteins, hormones, etc. For example, a localized increase in acidity and/or temperature can be perceived as a physical damage or an infection to the local area.
- the local cells may release beneficial proteins, enzymes, hormones, etc.
- a treatment or device may qualify as being gender specific.
- One way a treatment or device may be considered gender specific is to identify differences in product design or treatment between men and women.
- Another way to identify whether a device or treatment is gender specific is to determine who the intended patients are. For instance, a product line having two or more models where at least one model is marketed or designed more for men than women and another model is marketed or designed more for women than men would be gender-specific, and therefore within the scope of the invention. If there are measurable differences between the product design or treatment for men versus women, then another way to identify a product or treatment as gender-specific would be by having these differences meet or exceed a threshold amount. For example, in cases where two or more models are offered to account for gender differences at least one of the varying design parameters will differ by about 5 percent or more, and more preferably will differ by about 10 percent or more.
- differences in a range of sizes of a device may in some cases be by 5 percent or more or by 10 percent or more.
- other measurable differences such as quantity, concentration, or release rates of medications may differ by these numerical amounts.
- skilled artisans would readily appreciate that these differences may be applied to any other measurable design parameter of a device or treatment, including duration, amount, thickness, forces applied, diameter, width, height, volume, density, temperature, pH changes, or the like.
- a medical implant can be any prosthetic implant for use in a body, including, ankle, knee, hip, spine, neck, wrist, elbow or shoulder implants.
- the medical implant can be, but is not limited to, tissue, scaffold, biological implants, graft, tissue graft, screws, plate, rods, or similar devices.
- Pharmaceutical delivery of medication may also be provided in a gender-specific manner.
- the release and absorption rates of drugs are different for men and women.
- Oral medication for instance, may be absorbed differently due to resorption rates in the stomach, intestine, duodenum, abdomen, or the like.
- intravenous medications can react differently for men and women.
- the present invention contemplates an improved drug delivery that accounts for gender-specific differences.
- One such example of an improved, gender-specific drug delivery system is in chemotherapy, which is known for being a thermal gradient drug delivery. Since men and women have different temperatures, diurnal changes, and pH, drug-delivery systems would benefit from accounting for one or more of these differences.
- dosages and the route of administration e.g.
- oral release or intravenous may be varied for men and women.
- the initial dosage for men may differ from the initial dosage for women, the amount of drugs used in subsequent doses may differ, and the time period between subsequent doses also may differ between men and women.
- a medicine given to a man may involve a second dose 8 hours later, while for women the second dose may be 6 hours later, or based on diurnal curves of men and women.
- the system includes gender specific packaging material which differentiates use for male and female patients.
- the packaging material can include labeling or color coding to specify gender usage.
- the packaging material can include labeling, inserts, or product information which provides dosage information for both male and female patients.
- the packaging material 200 includes a label 202 affixed thereto or, in the alternative, incorporated into the packaging material 200 .
- the label 202 illustrated in FIG. 25 , provides information identifying the contents and usage of the packaging material 200 , which can include a gender specifier 204 .
- the gender specifier 204 identifies the gender that the contents of the packaging material 200 are intended for.
- the gender specifier 204 can be in pictorial, graphic, or text (or combination) form such as “FEMALE” or “MALE.” It is contemplated that the text form of the gender specifier 204 can be provided in a variety of languages, depending of the intended country of use.
- the gender specifier 204 can be in the form of a color coding, wherein a first color is used to indicate a female gender and a second color is used to indicate a male gender.
- the first and second colors may be selected from colors that are recognizable as gender indicators. For example, to indicate a female gender the first color can be pink while blue may be used to indicate a male gender.
- first and second colors can be any colors which are readably discernable as indicators of gender.
- the color coded gender specifier 204 is depicted as incorporating only a portion of the label 202 . However, it is contemplated that the entire label 202 can be color coded to specify gender.
- the gender specifier 204 can be a symbolic form for representing female and male genders.
- the gender specifier 204 can be the western culture ideograms for female and male genders, namely “ ⁇ ” for the female gender and “ ⁇ ” for the male gender.
- gender symbols can be any symbols which are readably discernable as indicators of gender.
- the label 202 can include additional information, including, the product name 206 and product technical information 208 .
- the product name 206 can be a name used by the company for the product, used to identify the origin of the product, such as CHARITE owned by DePuy Spine, Inc., for an artificial disc.
- the product name can be a generic or descriptive name of the product, such as ARTIFICIAL DISC.
- Additional technical information 208 can be provided, such as information relating to the size, material, date of manufacture, lot or control number, etc.
- the packaging material 200 is the gender specifier.
- the packaging material 200 can be color coded to indicate gender, wherein a first color is used to indicate a female gender and a second color is used to indicate a male gender.
- the first and second color are selected from colors that are recognizable a gender indicators.
- first color can be the color pink and to indicate a male gender the second color can be the color blue.
- first and second colors can be any colors which are readily discernable and indicators of gender.
- an exemplary medicine container 210 is provided, wherein the medicine container 210 includes a label 212 affixed thereto.
- the label 212 provides information identifying the contents 214 and usage of the enclosed medicine.
- the usage information includes the recommend dosage for each gender, wherein gender specifiers 216 and 218 annotate the gender dosage information 220 and 222 .
- the gender specifiers 216 and 218 can be in a text form, such as “FEMALE” and “MALE.”
- the gender specifiers 216 and 218 can be in the form of a color coding or in symbolic representations.
- a product insert can be provided in the medicine container 210 . Similar to the label 212 , the product insert can provide information identifying the contents and usage of the enclosed medicine, which can include gender specifiers used in conjunction with dosage information.
- RFID chips may be associated with equipment, instruments, or in sterile packaging so that identification of the intended gender for the devices may be quickly determined. This may be of particular benefit where it is difficult to visually determine the gender-specific design. For example, it may be difficult to visually confirm the intended gender of light sensitive therapeutics, internal components, sealed materials, or implanted devices. Likewise, instrumentation kits may involve several tools or devices that would be time-consuming to confirm are all intended for the same gender. By associating an RFID tag with these devices, however, the gender-specific information can be quickly retrieved. In one embodiment, RFID chips provided in packaged gender-specific drugs are used to determine remaining quantities of medicine.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Transplantation (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Robotics (AREA)
- Prostheses (AREA)
Abstract
Description
- This application is a continuation of U.S. application Ser. No. 16/376,626, filed Apr. 5, 2019, which is a continuation of U.S. application Ser. No. 15/597,631, filed May 17, 2017, which is a division of U.S. application Ser. No. 15/003,243, filed Jan. 21, 2016, now abandoned, which is a continuation of U.S. application Ser. No. 11/454,109, filed Jun. 15, 2006, now U.S. Pat. No. 9,301,845, which claims the benefit of U.S. Provisional Application Nos. 60/755,804, filed Jan. 3, 2006, and 60/690,653, filed Jun. 15, 2005, the contents of which are each incorporated herein by reference in their entirety.
- The present invention relates to gender specific pharmaceuticals.
- Some fields of study recognize and account for differences between men and women better than others. Psychologists, for example, may choose different therapeutic techniques to address certain emotional issues with a man than with a woman. Personal trainers likewise may employ different physical training regimen for men than for women, and may have different target goals for cardiovascular and muscular development.
- Some fields of medical study may even consider gender during diagnosis of an illness or injury, but most do not identify or consider gender differences in treatment protocols, medical implants, drug development, drug dosage and delivery, and the like. Instead, many treatments only account for differences based on body weight, or create distinctions only between infants, children and adults while ignoring potentially significant differences based on gender. In many instances, therefore, there has been little, if any, effort to refine medical science to account for differences between men and women.
- One reason that medical science has not advanced to account for gender differences in treatment may be due in part to a widely held perception that sexual dimorphism is relatively low in humans when compared to other animals, and therefore the differences often are ignored or overlooked. Sexual dimorphism is the systematic difference in form between individuals of different gender in the same species. This may include differences in size, color, or the presence of gender defining body parts, such as horns or antlers. While in humans, the male and female forms are perceived differently, they tend to have a low level of sexual dimorphism when compared to other species. For example, the body masses of both male and female humans are approximately normally distributed.
- However, despite this relative low-level sexual dimorphism when compared to other species, there are physiological, muscular, and skeletal differences in men and women that are of particular relevance to improved medical treatment. Many of these differences are present even between men and women of similar height, weight, and build, but currently are not taken into consideration when treating a patient. For example, the female brain has more intercellular connections than the male brain, which may account for why women generally are likely to recover more of their speech abilities after a stroke than men, yet medical treatment for men and women is virtually identical. Additionally, male bones tend to be larger in size, having greater lengths, thicknesses, and densities. Similarly, the joints in male and female bodies differ. For example, the notch width at the end of the femur in the knee joint tends to be wider in males than in females. Despite these differences, medical implants currently are limited to unisex designs. Further examples of differences between men and women may be found in metabolic rates, diurnal changes, range of motion. pH and hormonal changes, elasticity of body tissue, and susceptibility to diseases or medical conditions.
- For example, males and females metabolize medications at different rates and react differently to different types of medications. As a result of these differences, females may metabolize some analgesics and adjuvant drugs at different rates than men, among them oxycodone, tramadol, fentanyl, bupivacaine, and diazepam. Similarly, males may respond more favorably to tricyclic agents and females may get greater relief from selective serotonin reuptake.
- In spite of these differences, medical practitioners tend to treat male and female patients with a gender-neutral approach. At best, medicines may be prescribed based on weight or body mass index (BMI), without taking into account other, potentially more significant gender differences. Medical implants and instruments are provided in limited sizes (e.g., small, medium, and large), but each having similar geometric proportions, the same material construction, the same surface treatment, and the same therapeutic coating for men and women. In short, medical science has made little effort to account for many potentially significant gender differences.
- Perhaps another reason gender differences have not been incorporated into medical science is the additional complexity it would introduce for patients and health professionals. It may be difficult, for example, for a doctor, nurse, or pharmacist to keep track of different gender-specific dosage amounts, dosage rates, drug combinations, and the like. Likewise, a couple, such as a husband and wife, where both are being treated for the same medical condition may become confused if presented with different medicines, or with different dosage instructions (e.g. dosage amounts, dosage frequency, etc.) for medicines with the same active ingredient. Additionally, if both patients are taking the same brand of medication, it may be difficult to distinguish each person's medicine from the other.
- Regardless of the reason for the current state of medical science, it would be desirable to have more sophisticated medical treatments that better account for gender differences.
- The present invention provides a system and method for accounting for gender specific differences in medical treatment. This is achieved first by taking into account these differences so that a patient's therapy and treatment is more closely tailored to them. This includes, for example, providing gender specific treatment, medical devices, medicines, and/or instrumentation. These differences may result in different techniques being provided for treating bones or joints (such as the knee, hip, or spine), differences in drug selection, drug delivery and dosage, different implant designs, and different treatment for soft tissue repair. These and other non-limiting examples are further discussed in detail below.
- In addition, the invention also may involve improved identification systems that help patients or health professionals avoid or reduce potential confusion that may result from the availability of gender specific treatment options. For example, the medical treatment system can include a medical device identification system which differentiates use for male and female patients. The medical device identification system includes a container adapted to receive a medical device and a gender specifier. The gender specifier is used to identify the gender the medical device is designed for. The gender specifier can be incorporated into a label, where the gender specifier can be in text form, symbolic form or color coded. For example, the gender specifier can be in the text form “MALE” or “FEMALE.”
- The gender specifier may also be an electronic device, such as an RFID tag that is associated or packaged with the device or medicine so that it can be readily identified and associated for use with a particular gender. This embodiment of the invention may be of particular use for sterilized products, medicines that are sealed in a container, or in other situations where it is difficult to visually confirm for which sex the product is intended.
- Alternatively, the medical treatment system may include a medication container having a gender-specific labeling system. The label system may provide information identifying the contents and gender-specific instructions regarding usage of the enclosed medicine. The usage information may include, for example, the recommended dosage for one or both genders. Thus, the gender specifier may be dosage information, but also it may be in a text form, such as “FEMALE” and “MALE,” or alternatively may be in the form of a color coding or in symbolic representations.
- A more complete understanding of the present invention, and the attendant advantages and features thereof, will be more readily understood by reference to the following detailed description when considered in conjunction with the accompanying drawings wherein:
-
FIG. 1 depicts an exemplary knee joint; -
FIG. 2 depicts an exemplary prosthetic knee joint; -
FIG. 3 depicts an exemplary femoral component of a male prosthetic knee joint; -
FIG. 4 depicts an exemplary tibial component of a male prosthetic knee joint; -
FIG. 5 depicts an exemplary femoral component of a female prosthetic knee joint; -
FIG. 6 depicts an exemplary tibial component of a female prosthetic knee joint; -
FIG. 7 depicts an another exemplary femoral component of a prosthetic knee joint; -
FIG. 8 depicts an exemplary rotatable tibial component of a prosthetic knee joint; -
FIG. 9 depicts a partial cross section of the rotatable tibial component ofFIG. 8 : -
FIG. 10 depicts a platform of a rotatable tibial component of a prosthetic knee joint; -
FIG. 11 depicts a platform of a rotatable/translatable tibial component of a prosthetic knee joint; -
FIG. 12 depicts another platform of a rotatable/translatable tibial component of a prosthetic knee joint; -
FIG. 13 depicts an exemplary male patella with pegs or contact points arranged based on the male anatomy; -
FIG. 14 depicts an exemplary female patella with pegs or contact points arranged based on the female anatomy; -
FIG. 15 depicts an exemplary bi-compartmental femoral component of a male prosthetic knee joint; -
FIG. 16 depicts an exemplary bi-compartmental femoral component of a female prosthetic knee joint; -
FIG. 17 depicts a schematic diagram of a computer navigation system of the present invention; -
FIG. 18 depicts a triangular mapping of a femur portion of a knee joint; -
FIG. 19 depicts a triangular mapping of a tibia portion of a knee joint; -
FIG. 20 depicts an exemplary vascular stent; -
FIG. 21 depicts an exemplary female vascular stent; -
FIG. 22 depicts a cross sectional view of an embodiment of the stent ofFIG. 20 ; -
FIG. 23 depicts an exemplary medical implant including an energy sink: -
FIG. 24 depicts a representative packaging material of the present invention; -
FIG. 25 depicts a representative label affixed to the packaging material ofFIG. 24 ; -
FIG. 26 depicts a representative medicine container of the present invention; - The present invention provides a system and method for gender specific medical treatment. As mentioned above, gender differences are often ignored when determining how to treat a medical condition. It is believed that accounting for one or more of these differences during treatment may greatly improve the quality of care and degree of recovery that a patient experiences.
- One example where medical science currently applies a unisex approach is in the treatment of bones and joints. Three non-limiting examples discussed below—namely treatment of the knee, hip, and spine—illustrate how the invention may be used to improve the quality of care a patient may receive when gender differences are taken into account.
- Knee replacements, for instance, are about twice as likely to be performed on women as on men. There are gender-specific differences in the bones and joint associated with the knee that are not currently taken into account in this area of medicine. For example, the female patella is generally thinner and narrower in superior and inferior dimensions, while in men it is generally wider in proportion.
- Referring to
FIG. 1 , there is shown an anterior view of a knee joint 10, wherein the patella is not shown. The knee joint 10 includes afemoral portion 12 having medial andlateral condyles trochlear groove 18 is interposed between the medial andlateral condyles femur 12 as the knee joint 10 is flexed and extended. Atibial portion 20 of the knee joint 10 includes atibial plateau 22, including medial andlateral menisci 24 and 26 disposed on thetibial plateau 22. The medial andlateral condyles tibial plateau 22, engaging the medial andlateral menisci 24 and 26 allow for rotation of thetibia 20 with respect to thefemur 12 and shock absorption between thefemur 12 andtibia 20. A central longitudinal axis of thefemur portion 12 is aligned at an angle a with respect to a central longitudinal axis of thetibial portion 20. - Depending upon the degree and type of injury, a total or partial knee replacement procedure can be performed when a knee joint 10 is damaged. A total knee replacement may involve replacing or repairing up to three bone surfaces, namely the medial and
lateral condyles femur 12, thetibial plateau 22 of thetibia 20, and the back surface of the patella. Referring toFIG. 2 , an exemplaryprosthetic knee 28 includes afemoral component 30 and atibial component 32. Thefemoral component 30 is configured to curve about the cut end portions of the medial andlateral condyles trochlear groove 34 therein to allow tracking of the patella about thefemoral component 30 as the knee joint 10 is flexed and extended. Thetibial component 32 includesflat platform 36 with acushioning material 38, replacing the medial andlateral meniscus 24 and 26. - The femoral and
tibial components tibial components - As previously discussed, there are many skeletal differences between men and women, including bone structure, configuration, size, length, thickness, density, and geometric proportion. The male femur, for example, tends to be proportionally wider, has a greater thickness, and a wider trochlear groove. Additionally, because of the differences between the male and female pelvic structures, the angular relationship a, between the femur and the tibia in male and female knees is different. Currently, these differences are not accounted for in prosthetic design, whereas in the present invention one or more of these differences could be taken into account to provide gender-specific prosthetic design.
- Thus, one aspect of the present invention is directed to a prosthetic knee joint that is configured and dimensioned for gender specific use. To improve articulation for women, for instance, the prosthetic knee joint may have a reduced bearing surface, such as being reduced by 10 percent or more in comparison to a male prosthetic knee design. The reduced bearing surface would allow greater range of motion of the implant corresponding to the greater range of motion typically exhibited in women. Overall, the implant for women may also be significantly thinner, such as being at least 5 percent thinner, at least 10 percent thinner, or alternatively at least 20 percent thinner than implants for men. A formal prosthetic knee for women may also have one or more of the following: thinner runners to help improve range of motion, lesser amount of metal, or greater flexibility.
- If the female implant is significantly thinner or has a much smaller surface area contacting bone than a male implant, it may be desirable to provide more ingrowth surface on the female implant in order to enhance fixation. Fixation can also be increased by using a different amount or configuration of bone cement, the grouting material frequently used for fixation of a prosthetic component. In this regard, the present invention also contemplates female specific and male specific bone cement, with the composition of the female bone cement differing from the male bone cement. For example, fillers could be added to the PMMA (the principal component of the bone cement) to change the mechanical properties. Additionally, other components (such as an antibiotic) can be selected depending on whether the intended recipient is a male or a female. In this regard, a female bone cement may have added components to address the osteoporotic bone found in women. Such components include calcium supplements and other agents for promoting an osteogenic or osteoconductive effect (or slowing the process of bone demineralization).
- Referring to
FIG. 3 , a malefemoral component 40 of a knee joint implant of the present invention is provided. Thefemoral component 40 includes medial andlateral condyle portions trochlear groove 46 is disposed between the medial andlateral condyle portions femoral components 40 are provided in a range of sizes to span the normal size ranges of male human knee joints. Additionally, the thickness t1 and the material densities of thefemoral components 40 are selected to correspond to male bone thickness and densities. - Referring to
FIG. 4 , amale tibial component 48 of a knee joint of the present invention is provided. Thetibial component 48 includesflat platform 50, having a substantially oval shape, wherein thecushioning material 52 replaces the medial andlateral meniscus 24 and 26. Abone spike 54 is included for insertion into the prepared end of the tibia, securing thetibial component 48 to the tibia. Thebone spike 54 can be substantially conical in shape, having a maximum diameter d1 and length l1. - Referring to
FIG. 5 , a femalefemoral component 60 of a knee joint implant of the present invention is provided. Thefemoral component 60 includes medial andlateral condyle portions trochlear groove 66 is disposed between the medial andlateral condyle portions femoral components 60 are provided in a range of sizes to span the normal size ranges of female human knee joints. Additionally, the thickness t2 and the material densities of thefemoral components 60 are selected to correspond to female bone thickness and densities. - Referring to
FIG. 6 ,female tibial component 70 of a knee joint of the present invention is provided. - The
tibial component 70 includesflat platform 72, having a substantially elongated oval shape, wherein thecushioning material 74 replaces the medial andlateral meniscus 24 and 26. A bone spike 76 is included for insertion into the prepared end of the tibia, securing thetibial component 70 to the tibia. Thebone spike 74 can be substantially conical in shape, having a maximum diameter d2 and length h. - As previously discussed, the male
femoral component 40 will generally have greater widths W1 and W2 and the radius R1, thus bearing surface area, than that of comparable femalefemoral component 60 widths W3 and W4 and the radius R2. Similarly, the malefemoral component 40 will generally have a greater material thickness t1 than that of thickness t2 of a comparable femalefemoral component 60. Thus, a “large” size for a male prosthetic knee joint may differ significantly in size, proportion, and construction from a large-sized prosthetic knee joint for women. Furthermore, as shown inFIG. 5 , anupper section 68 of the femalefemoral component 60 can be generally narrower than that of a comparably malefemoral component 40, to accommodate structural differences between the female and male femurs. In other words the femalefemoral component 60 design can have scalloped edges compared to the malefemoral component 40 design. Additionally, the thickness, the material densities, and the material composition of thefemoral components femoral components - Similar to the
femoral components tibial components 58 and 70 are designed and configured for use in replacement of the knee joint in males and females. The dimensions of the tibial components once again may be provided in a range of sizes to span the normal size ranges of male and female human knee joints. As shown inFIGS. 4 and 6 , themale platform 50 has a substantially oval shape, whereas thefemale platform 72 has an elongated oval shape. The shapes of theplatforms femoral components tibial components - Thus, a gender-specific design may be identified by one component having less material than for the opposite sex. Furthermore, additional dimensions of the femoral portion of the knee joint can be utilized in the design and configuration of the femoral components. One or more of these dimensions may be varied so that an implant is more suited to a male or female patient. Thus, an implant design may be considered gender-specific if one or more of these parameters has been selected to better match either a male or female.
- A gender-specific prosthetic design may also be identified by comparing relative differences that exist between a female design and a male design. For example, if one or more dimensions (e.g., bearing surface area, widths, radii, curvature, thickness of material, amount of metal, range of motion, flexibility, etc.) or relative proportions (e.g., relative width or relative differences in angles, minimum or maximum sizes, etc.) or an implant design for one sex varies by more than 5 percent, or alternatively by 10 percent or more, or even by about 20 percent or more, from an implant designed for the opposite sex, then the design may qualify as being gender-specific.
- Referring to
FIG. 7 , anotherfemoral component 80 of a knee joint implant of the present invention is provided. Thefemoral component 80 includes medial andlateral condyle portions medial condyle portion 82 has a width Wm and a radius Rm and thelateral condyle portion 84 has a width WL and a radius RL, wherein the width Wm and WL can be of equal dimension, or in the alternative, the widths Wm and WL can be of non-equal dimension. Similarly, the medial andlateral condyle portions trochlear groove 86 is disposed between the medial andlateral condyle portions - In this manner, the widths Wm and WL and the radii Rm and RL of the
femoral components 80 can be provided in a range of sizes to more precisely emulate the size and dimensions of a male or female human knee joints. For example, the radii Rm and RL of the medial andlateral portions femoral component 80 can be selected such that the radius Rm of the medial condyle portion is larger with respect to the radius RL of the lateral condyle portion. As such, the radii Rm and RL of the medial andlateral portions femoral components 80 are selected to correspond to male or female bone thickness and densities. - As previously discussed, a male femoral component will generally have greater widths Wm and WL and the radii Rm and RL, thus bearing surface areas, than that of a comparable female femoral component widths Wm and WL and the radii Rm and RL. Similarly, the male femoral component will generally have a greater material thickness t3 than that of thickness of a comparable female femoral component. Thus, a “large” size for a male prosthetic knee joint may differ significantly in size, proportion, and construction from a large-sized prosthetic knee joint for women. Furthermore, as shown in
FIG. 5 , an upper section of the female femoral component can be generally narrower than that of a comparably sized male femoral component to accommodate structural differences between the female and male femurs. In other words a female femoral component design can have scalloped edges compared to the male femoral component design. Additionally, the thickness, the material densities, and the material composition of the femoral components may be selected to correspond to different male and female bone thickness and densities. Additional dimensions of the femoral portion of the knee joint can be utilized in the design and configuration of the femoral components. - Referring to
FIG. 8 , atibial component 90 of a knee joint of the present invention is provided. Thetibial component 90 includes aplatform 92, having a substantially oval shape, wherein acushioning material 94 replaces the medial andlateral meniscus 24 and 26. Abone spike 96 is included for insertion into the prepared end of the tibia, securing thetibial component 90 to the tibia. Thebone spike 96 can be substantially conical in shape, having a maximum diameter d1 and length l1. Theplatform 92 can be rotatably connected to thebone spike 96, such that theplatform 92 can rotated with respect to the central longitudinal axis “A” of thebone spike 96. - In an embodiment as shown in
FIG. 9 , theplatform 92 includes a slottedsection 98, in which ahead portion 100 of thebone spike 96 is positioned. The slottedsection 98 is configured to capture thehead portion 100 of thebone spike 96, securing thehead portion 100 within the slottedsection 98, yet allowing theplatform 92 to rotate with respect with thebone spike 96. In this manner, theplatform 92 can rotate with respect to a femoral component as the knee joint is moved between flexion and extension, thereby decreasing the frictional forces between the contacting surfaces of the femoral component and a cushioning material of theplatform 92. Furthermore, the rotation of theplatform 92 can decrease the stresses provided on the implant/bone interface, decreasing the likelihood of failure and increasing the life expectancy of the implant. It is contemplated that the other rotational, translation, and positional configurations of theplatform 92 with respect to thebone spike 96 can be provided to further increase the efficiency of emulating a natural knee joint and accounting for the anatomical differences between male and female joints. - Referring to
FIG. 10 , thebone spike 96 can be centrally positioned on theflat platform 92, such that thecenter 102 of theplatform 92 is aligned along the central longitudinal axis of thebone spike 96. Alternatively, thebone spike 96′ can be positioned offset from thecenter 102 of theplatform 92, such that thecenter 102 of theplatform 92 is rotatable about thebone spike 96′. - Referring to
FIG. 11 , theplatform 92 can include an elongated slottedsection 104, such that theplatform 92 can slide in the anterior and posterior directions as the knee joint is moved between flexion and extension. In addition, theplatform 92 can rotate with respect to thebone spike 96 as the knee joint is moved between flexion and extension. In this manner, the compound movement for theplatform 92 can be used to emulate high flexion. - Referring to
FIG. 12 , theplatform 92 includes an angular elongated slottedsection 106, such that theplatform 92 can slide substantially in the anterior/posterior and medial/lateral directions as the knee joint is moved between flexion and extension. In addition, theplatform 92 can rotate with respect to thebone spike 96 as the knee joint is moved between flexion and extension. - Similar to the femoral components, the
tibial components 90 are designed and configured for use in replacement of the knee joint in males and females. The dimensions of the tibial components once again may be provided in a range of sizes to span the normal size ranges of male and female human knee joints. As showing inFIGS. 4 and 6 , themale platform 50 has a substantially oval shape, whereas thefemale platform 72 has an elongated oval shape. The shapes of theplatforms femoral components tibial component 90. - Referring to
FIGS. 13 and 14 , amale patella 110 and afemale patella 112 are provided. As shown in these figures, the male and female patellas 110 and 112 have substantially different shapes, where thefemale patella 112 is more elongated with respect to themale patella 110. As such, when replacement patellas are provided, they are provided in accordance with the gender of the patient. - Furthermore, in surgical procedures requiring resurfacing of the patella surfaces, contact pegs 114 can be affixed to the surface, providing multiple point contact surfaces between the patella and the femur or femoral implant. As male and female patellas 110 and 112 have different shapes, the arrangement of the
pegs 114 can be changed accordingly. As shown inFIG. 13 , thepegs 114 are positioned in a substantially triangular configuration for the male patella, allowing for the wider surface of themale patella 110. As shown inFIG. 14 , thepegs 114 are positioned in a substantially linear configuration, allowing for the more linear surface of thefemale patella 114. Providing such contact pegs (rather than replacing or resurfacing the entire patella) offers a number of advantages, which include greater applicability to minimally invasive procedures, reduced articulating surface area, etc. Published U.S. Patent Application Publication No. US 2003/0028196 A1 discloses a number of such pegs or reduced bearing surface implants that can be used with the present invention. The entire content of this patent application is incorporated herein by reference. - Although
FIGS. 2-14 , show total knee replacement components, the present invention is well-suited for partial knee replacement components such as uni-compartmental and bi-compartmental implants. The present invention also contemplates the use for re-surfacing and surface bearing procedures and/or components. - Referring to
FIG. 15 , a bi-compartmental malefemoral component 120 of a knee joint implant of the present invention is provided. Thefemoral component 120 includes medial andlateral components medial component 122 includes amedial condyle portion 126 having a width Wm and a radius Rm. Thelateral component 124 includes a lateral condyle portion 128 having a width WL and a radius RL. As previously discussed, the widths Wm and WL can be of equal dimension or can be of different dimensions. Similarly, the medial andlateral condyle portions 126 and 128 radii Rm and RL can be of equal dimension or can be of non-equal dimension. Atrochlear groove 130 formed by the combination of the medial andlateral components lateral condyle portions 126 and 128 and has a width W1. - Referring to
FIG. 16 , a bi-compartmental femalefemoral component 140 of a knee joint implant of the present invention is provided. Thefemoral component 140 includes medial andlateral components medial component 142 includes amedial condyle portion 146 having a width Wm and a radius Rm. Thelateral component 144 includes alateral condyle portion 148 having a width WL and a radius RL. As previously discussed, the widths Wm and WL can be of equal dimension or can be of different dimensions. Similarly, the medial andlateral condyle portions trochlear groove 150 formed by the combination of the medial andlateral components lateral condyle portions - As previously discussed, male femoral components will generally have greater widths Wm and WL and radii Rm and RL, thus bearing surface area, than that of comparable female femoral components widths Wm and WL and radii Rm and RL. Similarly, the male femoral components will generally have a greater material thickness t1 than that of thickness of a comparable female femoral component. Thus, a “large” size for a male prosthetic knee joint may differ significantly in size, proportion, and construction from a large-sized prosthetic knee joint for women. Furthermore, as shown in
FIGS. 15 and 16 , anupper section 152 of the femalefemoral components femoral components upper section 152 is such that the femalefemoral components femoral components femoral components femoral components - Thus, a gender-specific design may be identified by one component having less material than for the opposite sex. Furthermore, additional dimensions of the femoral portion of the knee joint can be utilized in the design and configuration of the femoral components. One or more of these dimensions may be varied so that an implant is better suited to a male or female patient. Thus, an implant design may be considered gender-specific if one or more of these parameters has been selected to better match either a male or female.
- A gender-specific prosthetic design may also be identified by comparing relative differences that exist between a female design and a male design. For example, if one or more dimensions (e.g., bearing surface area, widths, radii, curvature, thickness of material, amount of metal, range of motion, flexibility, etc.) or relative proportions (e.g., relative width or relative differences in angles, minimum or maximum sizes, etc.) or an implant design for one sex varies by more than 5 percent, or alternatively by 10 percent or more, or even by about 20 percent or more, from an implant designed for the opposite sex, then the design may qualify as being gender-specific.
- Referring to
FIG. 17 , acomputer navigation system 160 of the present invention is provided and schematically shown. Thecomputer navigation system 160 includes a central processing unit (CPU) 162, having aprocessor 164 andmemory 166, adisplay device 168, and input devices, including akeyboard 170 and astylus 172. A computer program is stored on theCPU 162, where the computer program can be used to aid in the selection, preparation, and insertion of implants into a patient. Thestylus 172 can be used to provide single point locations or multiple point locations to outline the contours of a surface of a portion of a joint. Thenavigation system 160 can further include aprinter 174. - An anatomical database is stored on the
CPU 162 and is accessible by the computer program to determine appropriate implants for use in the patient. In an embodiment, the anatomical database includes information relating to a joint in the body of a patient, for example a knee joint. The anatomical database includes a library of joint mappings, having a broad range of joint sizes, as well as including information relating to gender differences in the joints. For example, the anatomical database can include information on bone thickness, density, the radii of the medial and lateral condyles, the widths of the medial and lateral condyles, the width of the trochlear groove, and the angular relationship of the medial and lateral condyles with respect to the central longitudinal axis of the femur for a broad range of different size joints for male and females. In other words, conventional computer navigation systems include a library or database of anatomical parameters that are used in the registration or other calibrating process, but the anatomical parameters are based on a unisex model that represents a composite of male and female anatomies. In contrast, the computer navigation system of the present invention includes a male library or database and a female library or database. The separate libraries or databases include differences in the anatomy. Exemplary differences have been discussed previously and additional gender differences are described below. Thus, with the computer navigation system of the present invention, the patient's gender is selected and the appropriate library or database is used in the registration or other calibrating process. - In a method of use, the
stylus 172 is used to the map the joint, with at least three points located on the joint to determine the anatomical parameters of the joint. The joint mapping is displayed on thedisplay device 168. Referring toFIG. 18 , in a knee joint 10 thestylus 172 maps thefemoral portion 12 of the knee joint 10. Thestylus 172 is used to locate a home point “HP” on thefemur 12, where the home point lies on the top surface on thefemur 10 in a plane defined by the central longitudinal axis “A” of thefemur 10. At least two additional points “P1” and “P2” are located with respect to the home point, such as end surfaces of the medial andlateral condyles femoral portion 12 of the knee joint 10, which is displayed on thedisplay device 168. In addition to the triangular mapping, gender information is also provided. - In an alternative embodiment, the
display device 168 displays a generic knee joint, highlighting a point on the joint to be located using thestylus 172. For example, a home point “HP” and the end surfaces of the medial and lateral condyles are highlighted on the generic knee joint. Thestylus 172 is utilized to locate the corresponding points on theknee joint 10 of the patient. - The computer program utilizes the mapped points and the gender information to provide a preliminary model for the
femoral portion 12, which is displayed on thedisplay device 168. The preliminary model is based on a statistical analyzing of the relationship of the mapped points and the gender information, in comparison to the knee joint database. The resulting preliminary model can include information on the radii of the medial and lateral condyles, the widths of the medial and lateral condyles, the width of the trochlear groove, and the angular relationship of the medial and lateral condyles with respect to the central longitudinal axis of the femur. Based on the preliminary model an appropriately size femoral implant can be selected for use, as well as a corresponding cutting pattern for that implant. - The above system has been described as using three points to provide a triangular mapping. However, it is understood that additional information can be utilized to provide a more refined model of the
femoral portion 12 of the knee joint 10. For examples, theinput device 170 can be used to map anterior and posterior points of the medial and lateral condyles, the femoral contacting surface of the medial and lateral condyles, the trochlear groove, etc. Additional information, such as the bone diameter and angular relationship between the femur and the pelvis can be utilized to refine the model. - Referring to
FIG. 19 , in a similar method, thecomputer navigation system 160 can be used to map thetibial portion 20 of the knee joint 10. Thestylus 172 is used to locate reference points on the end portion of thetibia 20 with respect to the home point “HP” on thefemur 12. For example, thestylus 172 can be used to map points along thetibial plateau 22, including the tibial plateau end points P3 and P4, to providing a triangular model “T2” of thetibia 20 as well as the angular relationship “a” between thetibia 20 andfemur 12. - The computer program utilizes the mapped points and the gender information to provide a preliminary model for the
tibial portion 20, which is displayed on thedisplay device 168. Thetibial portion 20 can be displayed either individually or in relation to thefemoral portion 12. The resulting preliminary model can be used to select an appropriately sized tibial implant, as well as a corresponding cutting pattern for that implant. The selection of the femoral and tibial implants is not only based on the inputted data, by also on the implants themselves, and their ability to function appropriately together. - Other gender-specific differences may be used to further customize a medical implant such as a prosthetic knee for men or women. For instance, surfaces of the device may have different ingrowth surfaces, porosity. HA, or BMP coated or bonded to it.
- In addition to the knee joint, additional prosthetic implants can be designed and configured for gender specific use. For example, as noted above, the female pelvis is distinguished from that of the male by its bones being more delicate and shallower in depth. The ilia of the female pelvis are less sloped, and the anterior iliac spines more widely separated; hence the greater lateral prominence of the hips in females. The superior aperture of the lesser pelvis is larger in the female than in the male; it is more nearly circular, and its obliquity is greater. The inferior aperture is larger and the coccyx more movable. The sciatic notches are wider and shallower, and the spines of the ischia project less inward. The ischial tuberosities and the acetabula are wider apart, and the former are more everted. The pubic symphysis is less deep, and the pubic arch is wider and more rounded than in the male, where it is an angle rather than an arch.
- Because of the differences between the male pelvis and the female pelvis, hip configuration and alignment differ between the genders. Such differences require differing implant configurations. In accordance with the present invention, prosthetic hip implants may be designed and configured for gender specific use, taking into account the structural differences between the female and male pelvis and connecting femurs.
- Thus, another example of where the present invention may be used to improve currently available implant designs is in treatment of injuries to the pelvis or hip. As mentioned above, an implant designed for women may be designed to provide greater range of motion than a similar implant designed for men. Females often benefit from having a greater range of motion for hips just as they do for knees. Thus, the female design may be more flexible in the acetabular component, more flexible in the femoral stem, or have a greater modulus of elasticity (especially in more osteoporotic bone). Designing the female prosthetic so that the femoral head contacts a thinner acetabulum also may change range of motion and stability to be more suitable for women than men.
- Additionally, the offset for the femoral head and neck region may be different for men than women. For example, a female design may have less offset while a male design may have a greater offset to increase the lever arm. The difference in offset may be about 5 percent or greater in one embodiment, although as described above the offset may differ by 10 percent or more, or by 20 percent or more.
- Another way in which prosthetic designs such as the hip may incorporate gender-specific features is with the use of different ingrowth surfaces. For example, the superior portion under compression on the acetabular component may have HA coating and/or a roughened surface texture for one gender while less or no HA coating and/or a smoother surface texture for the opposite gender. Likewise, the inferior coating may be porous or fiber metal coating or porous tantalum coating so that there would be two or more ingrowth surfaces on the same gender-specific implant.
- Since it may be difficult to immediately recognize some of these gender-specific design differences, one or more components may be color-coded so that they may be more readily identified by visual inspection. For example, the rotating or bearing surface of the femoral head may have one color for women and another color for men. Thus, a component having a pink visible surface may signify that the gender-specific design of the implant is for women, while a black surface may signify that the gender-specific design is for men. This color-coding of one or more components may be used in place of or in conjunction with any other gender identification systems, including those described elsewhere herein.
- It is further contemplated the gender specific prosthetic implants can be designed and configured for use in the any joint in a body, including ankle, knee, hip, spine, neck, wrist, elbow, and shoulder. In spine treatment, for example, a nucleus pulposes implant for women may have greater elasticity or greater hydrophilic capability. Likewise for spinal implants, the shape, angle, or distance distracted between the disc space may be designed to be gender-specific for men and women. In addition, disc replacement technology may have gender-specific features such as differences in disc height or angulation changes such as lordosis or rotational angle. Likewise, a spinal cage could have gender-specific designs that vary in thickness or forced expansion.
- Bone cement, such as used in spine treatment or in treating other bones in the body, also may have a different viscosity for men and women, different rates of introduction into the body, or different amounts of bonding or interdigitation, especially with osteoporotic bone in females versus males.
- The use of gender-specific designs also may result in kits of implants, tools and devices tailored primarily for a particular gender. For instance, a kit of implants of varying sizes intended for women may have a generally smaller size than a kit of similar implants intended for men. Providing a gender-specific kit allows for the reduction or elimination of conventional kit components that might primarily be intended for use on the opposite sex. Likewise, there may be differences in the tools and instruments provided in one kit versus another due to anatomical, physiological, or other differences between men and women. One benefit of providing gender-specific kits is that it may reduce the amount of variety of devices and instruments that may be prepared for a particular surgery. The potential reduction in complexity and number of devices and instrumentation may in turn allow a physician to perform surgeries more efficiently and successfully.
- Sutures also may be designed to have gender-specific features. Today, suture materials are all designed to have the same properties for men and women. Under the present invention, however, suture material may have greater elasticity for females than for males.
- Stents are another example where a currently unisex approach could be improved by taking into account gender-specific differences. Stents are used in a wide variety of applications, such as for aneurysms, aortic, cardiac, carotid, vascular anastomosis, vascular angioplasty, and the like. As is well known stents are typically inserted in a compressed state and then expanded when in position. The expansion of stents today is the same for men and women; yet female vessel tissue tends to be more elastic than in men. Therefore, it is believed the vessels in women would apply a less resistance to an opening stent than in men. While this difference is not currently taken into account, one embodiment of the present invention would be to design a stent to require a lower opening force for women than a stent designed for men. For example, a balloon used to expand a male designed stent may apply a greater opening force than a balloon used to expand a female designed stent.
- Furthermore, stent expansion may involve less elasticity and greater stiffness in men than in women since male vessel tissue is generally more rigid than for women. Since female tissue often is more pliable, a female stent design may have a lower modulus of elasticity to expand, may be more elastic, and less rigid. In addition, a male stent design may have differences in drug release than in women. For example, a male stent design may have a greater drug release associated with it, may have specific localized drug release, or a greater concentration of drug released over a shorter period. Additionally, different drug combinations may be associated with a male stent design than for a female stent design. The stent may have multiple layers for providing different drug deliveries for men and women. For example, one layer may be porous or permeable that allows a drug to be released from an inner coating or layer. The porous or permeable coating or layer may have different apertures for men than for women, thereby providing a gender-specific drug delivery. In addition, the coatings or layers may react differently to temperature, pH, or other differences in the intended environment that may be present between men and women. For example, a porous or permeable layer may have an outer coating that dissolves when deployed in a female, thereby allowing the inner coating or layer to be released into the body, but remains substantially intact during exposure in a male body. Alternatively, the outer coating may have a different rate of degradation for men than women, thereby allowing for gender-specific rates of drug delivery.
-
FIG. 20 illustrates an embodiment of the invention concerning anarterial stent 180. Stents are particularly useful in the treatment and repair of blood vessels after a stenosis has been compressed by percutaneous transluminal coronary angioplasty (PTCA), percutaneous transluminal angioplasty (PTA), or removed by atherectomy or other means, to help improve the results of the procedure and reduce the possibility of restenosis. Stents also can be used to provide primary compression to a stenosis in cases in which no initial PTCA or PTA procedure is performed. While stents are most often used in the procedures mentioned above, they also can be implanted on another body lumen such as the carotid arteries, peripheral vessels, urethra, esophagus and bile duct. - In typical PTCA procedures, a guiding catheter or sheath is percutaneously introduced into the cardiovascular system of a patient through the femoral arteries and advanced through the vasculature until the distal end of the guiding catheter is in the aorta. A guidewire and a dilatation catheter having a balloon on the distal end are introduced through the guiding catheter with the dilatation catheter sliding over the guidewire. The guidewire is first advanced out of the guiding catheter into the patient's vasculature and is directed across the arterial lesion. The dilatation catheter is subsequently advanced over the previously advanced guidewire until the dilatation balloon is properly positioned across the arterial lesion. Once in position across the lesion, the expandable balloon is inflated to a predetermined size, such as with a radiopaque liquid, at relatively high pressure to displace the atherosclerotic plaque of the lesion against the inside of the artery wall and thereby dilate the lumen of the artery. The balloon is then deflated to a small profile so that the dilatation catheter can be withdrawn from the patient's vasculature and the blood flow resumed through the dilated artery. As should be appreciated by those skilled in the art, while the above-described procedure is typical, it is not the only method used in angioplasty.
- In angioplasty procedures of the kind referenced above, abrupt reclosure may occur or restenosis of the artery may develop over time, which may require another angioplasty procedure, a surgical bypass operation, or some other method of repairing or strengthening the area. To reduce the likelihood of the occurrence of abrupt reclosure and to strengthen the area, a physician can implant an intravascular prosthesis for maintaining vascular patency, commonly known as a stent, inside the artery across the lesion. Stents are generally cylindrically shaped devices which function to hold open and sometimes expand a segment of a blood vessel or other arterial lumen, such as a coronary artery. Stents are delivered in a radially compressed condition to the target location and then are deployed into an expanded condition to support the vessel and help maintain it in an open position. In one embodiment, the stent may be a self-expanding type formed from, for example, shape memory metals or super-elastic nickel-titanium (NiTi) alloys, which will automatically expand from a compressed state when the stent is advanced out of the distal end of the delivery catheter into the body lumen.
- Physiological differences between the female and male genders may also be found in the cardiovascular systems of men and women. For example, women, on average, have smaller diameter and thinner-walled arteries than men. The invention accounts for these physiological differences by providing different stent designs for men and women. Thus, the invention provides
stents 180 that are configured and dimensioned for gender specific use. As noted above, upon insertion into an artery, thestent 180 expands from an initial, compact condition to an expanded condition having a diameter D1, wherein the rate of expansion E is dependent on the material properties of thestent 180. In the expanded condition, the diameter D1 is of sufficient size to impart an expansive force Fe onto the inner arterial wall. - In a first embodiment, the
stent 180 is designed and configured for use in angioplasty procedures in males. One ormore stents 180 may be provided having at least one rate of expansion E and at least one expanded diameter D1 configured and dimensioned to span the normal size ranges of male human arteries. Additionally, the expansive force Fe imparted onto the inner arterial wall is a function of the arterial wall thickness, such that the expansive force Fe is of sufficient strength to maintain the artery in an open condition preventing reclosure, without damage to the inner arterial wall. Furthermore, additional dimensions of the arteries can be utilized in the design and configuration of thestent 180. - In a second embodiment, shown in
FIG. 21 , thestent 182 is designed and configured for use in angioplasty procedures in females. Once again, one ormore stents 182 may be provided having at least one rate of expansion E and at least one expanded diameter D2 configured and dimensioned to span the normal size ranges of female human arteries. Additionally, the expansive force Fe imparted onto the inner arterial wall is a function of the arterial wall thickness, such that the expansive force is of sufficient strength to maintain the artery in an open condition preventing reclosure, without damage to the inner arterial wall. Furthermore, additional dimensions, gender-specific features, or other parameters of the arteries can be utilized in the designed and configuration of the genderspecific stent 182. For instance, thestent 82 also may account for the effect of an illness or medical condition on the strength, size, or thickness of a vessel or vessel wall, which optionally may also be dependent at least in part upon gender. Some of the structural features of the stents that account for gender-specific differences include the following:stent 182 has ends that flare outwardly, whilestent 80 is substantially cylindrical;stent 182 has fewer openings thanstent 180; and the openings in the sidewall ofstent 182 are generally larger than the openings in the sidewall ofstent 180. - As discussed above, coatings can be used to make stent designs gender specific. It is well known that the
stents pharmaceutical agent 184. As shown inFIG. 22 , thepharmaceutical agent 184 can be combined with acoating 186 or other medium used for controlled release rates of thepharmaceutical agent 184. Thepharmaceutical agent 184 can be incorporated into or covered by a monolithic layer or coating, wherein theagent 184 diffuses through thecoating 186 and is released into the surrounding fluid. Alternatively, thecoating 186 can be a degradable coating, such that as thecoating 186 degrades thepharmaceutical agent 184 is released. - The
pharmaceutical agent 184 can be a drug used for the prevention or treatment of restenosis. Formulations useful for restenosis prevention or treatment can include, but ar not limited to, heparin and heparin fragments, colchicine, taxol, agiotensin converting enzyme (ACE) inhibitors, angiopeptin, Cyclosporin A, goat-anti-rabbit PDGF antibody, terbinafine, trapidil, interferon-gamma, steroids, ionizing radiation, fusion toxins, antisense oligonucleotides, gene vectors, and rapamycin. - In addition to or as an alternative to, the
pharmaceutical agent 184 may be a therapeutic biologic agent. Examples of such agents include, but am not limited to, hormones, cells, fetal cells, stem cells, bone morphogenic proteins (BMPs), tissue inductive factors, enzymes, proteins, RNA, viruses, etc. - As previously discussed, men and women may metabolize some medications at different rates and react differently to different types of medications. Just as the size, shape, and other performance characteristics of a stent may be tailored or customized primarily for a particular gender, the pharmaceutical agents used with the stents also may be tailored primarily for a particular gender. Thus, one embodiment of the invention provides a
coated stents - It should be noted that customizations of devices or treatments according to the invention may be used individually or in combination with other embodiments described herein or variations thereto. For instance, a single stent construction used for both men and women may have different coatings intended primarily for different genders. In addition, however, different coatings may also be used on different stent constructions that are designed primarily for a particular gender.
- In one embodiment using a
pharmaceutical agent 184 coated onto thestent pharmaceutical agent 184 release rate and dosage are selected to correspond to expected male metabolization and reactions. Acoating 186 may also be provided on thestent pharmaceutical agent 184 is covered by or incorporated into thecoating 186. Thecoating 186 may be used to control the timing and release rate of thepharmaceutical agent 184. For example, thepharmaceutical agent 184 may be released gradually through diffusion through thecoating 184 or after at least partial degradation of thecoating 186. In this manner, thecoating 186 can be designed and configured to release thepharmaceutical agent 184 at a rate and dosage corresponding to metabolization and potential reactions of primarily either men or women. - Similarly, the
pharmaceutical agent 184 release rate and dosage may be selected to correspond to expected female metabolization and reactions in the same manner. - While in the foregoing a
stent - A gender-specific design may also involve altering or controlling the treated area differently for men than for women. Referring to
FIG. 23 a medical implant in the form of a prosthetic knee joint 190, including a femoral andtibial component femoral component 192 is configured to provide a localized environmental change in a body of a patient. A localized increase in temperature can have beneficial effects, which include (but are not limited to): aiding in the alleviation of localized pain, fighting of local infections, and increasing vascular flow and permeability of vessels at the treatment site to control delivery of pharmaceutical agent. For example, a localized increasing in temperature increases the permeability of the local tissue, allowing for an increased and more efficient absorption of the pharmaceutical agent into the treatment site. - The
femoral component 192 includes anenergy sink 196, wherein theenergy sink 196 can be used to control the localized temperature of the surrounding tissue. For example, theenergy sink 196 can be a heat sink, wherein theheat sink 196 is charged by an internal orexternal energy unit 198. Theheat sink 196 produces a local increase in temperature. - The male and female genders react differently to localized changes in temperatures. For example, a localized increase in temperature of B degrees may have beneficial effect on a female, but no effect on a male. As a result of the differing effects on the male and the female genders, the applied energy is gender dependent. For example, in a female X amount of energy may be required to heat the
heat sink 196 to sufficiently raise the localize temperature to have a beneficial effect. In contrast, in a male, Y amount of energy may be required to heat theheat sink 196 to sufficiently raise the localize temperature to have a beneficial effect, wherein Y is greater than X. In accordance with the present invention, the applied energy and heat sink of afemoral component 192 are designed and configured for gender specific use, taking into account the reactive differences between the female and male genders. - Similarly, a localized change in pH can have similar beneficial effects, which include (but are not limited to): aiding in the alleviation of localized pain, fighting of local infections, and increasing vascular flow and permeability of vessels at the treatment site to control delivery of pharmaceutical agent. For example, a localized increase in pH may increase the permeability of the local tissue, thereby allowing for an increased and more efficient absorption of the pharmaceutical agent into the treatment site.
- The
energy sink 196 in thefemoral component 192 can be apH sink 196. ThepH sink 196 can be incorporated into thefemoral component 192 or be positioned separate from thefemoral component 192. Therefore, thepH sink 196 may be configured to release a chemical to produce either an increase or decrease in the local pH in order to provide a more gender-specific use. An acidic agent would lower the pH and a basic agent would raise the pH. Such agents are well-known to those of ordinary skill. - The male and female genders react differently to localized changes in pH. For example, a localized increase or decrease in the acidity of the surrounding tissue may have a beneficial effect on a female, but no effect on a male. As a result of the different effects on the male and the female genders, the chemical and release rate thereof is dependent on the gender of the patient. As such, in accordance with the present invention, the
pH sink 196 is designed and configured for gender specific use, taking into account the reactive differences between the female and male genders. - Additionally, temperature or pH changes may also be used to induce the release of beneficial enzymes, proteins, hormones, etc. from the cells in the treatment site. For example, a localized increase in acidity and/or temperature can be perceived as a physical damage or an infection to the local area. In response, the local cells may release beneficial proteins, enzymes, hormones, etc.
- There am several ways to define how a treatment or device may qualify as being gender specific. One way a treatment or device may be considered gender specific is to identify differences in product design or treatment between men and women. Another way to identify whether a device or treatment is gender specific is to determine who the intended patients are. For instance, a product line having two or more models where at least one model is marketed or designed more for men than women and another model is marketed or designed more for women than men would be gender-specific, and therefore within the scope of the invention. If there are measurable differences between the product design or treatment for men versus women, then another way to identify a product or treatment as gender-specific would be by having these differences meet or exceed a threshold amount. For example, in cases where two or more models are offered to account for gender differences at least one of the varying design parameters will differ by about 5 percent or more, and more preferably will differ by about 10 percent or more.
- Thus, differences in a range of sizes of a device may in some cases be by 5 percent or more or by 10 percent or more. Likewise, other measurable differences, such as quantity, concentration, or release rates of medications may differ by these numerical amounts. Of course, skilled artisans would readily appreciate that these differences may be applied to any other measurable design parameter of a device or treatment, including duration, amount, thickness, forces applied, diameter, width, height, volume, density, temperature, pH changes, or the like.
- Furthermore, while one exemplary embodiment of a medical implant discussed above refers to a prosthetic knee joint, it is contemplated that the medical implant can be any prosthetic implant for use in a body, including, ankle, knee, hip, spine, neck, wrist, elbow or shoulder implants. Furthermore, the medical implant can be, but is not limited to, tissue, scaffold, biological implants, graft, tissue graft, screws, plate, rods, or similar devices.
- Pharmaceutical delivery of medication may also be provided in a gender-specific manner. The release and absorption rates of drugs are different for men and women. Oral medication, for instance, may be absorbed differently due to resorption rates in the stomach, intestine, duodenum, abdomen, or the like. Likewise, intravenous medications can react differently for men and women. The present invention contemplates an improved drug delivery that accounts for gender-specific differences. One such example of an improved, gender-specific drug delivery system is in chemotherapy, which is known for being a thermal gradient drug delivery. Since men and women have different temperatures, diurnal changes, and pH, drug-delivery systems would benefit from accounting for one or more of these differences. For example, dosages and the route of administration (e.g. oral release or intravenous) may be varied for men and women. The initial dosage for men may differ from the initial dosage for women, the amount of drugs used in subsequent doses may differ, and the time period between subsequent doses also may differ between men and women. Thus, a medicine given to a man may involve a second dose 8 hours later, while for women the second dose may be 6 hours later, or based on diurnal curves of men and women.
- As noted previously, one consequence of accounting for gender-specific difference in medical treatment is that medical treatment may become more complicated or difficult. This additional complexity, however, can be reduced by providing gender-specific indictors on the devices, packaging, or instructions.
- The system includes gender specific packaging material which differentiates use for male and female patients. The packaging material can include labeling or color coding to specify gender usage. For medications, the packaging material can include labeling, inserts, or product information which provides dosage information for both male and female patients.
- Referring now to
FIG. 24 , aproduct packaging material 200 of the present invention is shown. Thepackaging material 200 includes alabel 202 affixed thereto or, in the alternative, incorporated into thepackaging material 200. Thelabel 202, illustrated inFIG. 25 , provides information identifying the contents and usage of thepackaging material 200, which can include agender specifier 204. Thegender specifier 204 identifies the gender that the contents of thepackaging material 200 are intended for. For example, thegender specifier 204 can be in pictorial, graphic, or text (or combination) form such as “FEMALE” or “MALE.” It is contemplated that the text form of thegender specifier 204 can be provided in a variety of languages, depending of the intended country of use. - Alternatively, the
gender specifier 204 can be in the form of a color coding, wherein a first color is used to indicate a female gender and a second color is used to indicate a male gender. The first and second colors may be selected from colors that are recognizable as gender indicators. For example, to indicate a female gender the first color can be pink while blue may be used to indicate a male gender. However, it is contemplated that first and second colors can be any colors which are readably discernable as indicators of gender. The color codedgender specifier 204 is depicted as incorporating only a portion of thelabel 202. However, it is contemplated that theentire label 202 can be color coded to specify gender. - In a further embodiment, the
gender specifier 204 can be a symbolic form for representing female and male genders. For example, thegender specifier 204 can be the western culture ideograms for female and male genders, namely “♀” for the female gender and “♂” for the male gender. However, it is contemplated that gender symbols can be any symbols which are readably discernable as indicators of gender. - The
label 202 can include additional information, including, theproduct name 206 and producttechnical information 208. Theproduct name 206 can be a name used by the company for the product, used to identify the origin of the product, such as CHARITE owned by DePuy Spine, Inc., for an artificial disc. Alternatively, the product name can be a generic or descriptive name of the product, such as ARTIFICIAL DISC. Additionaltechnical information 208 can be provided, such as information relating to the size, material, date of manufacture, lot or control number, etc. - In an alternative embodiment, the
packaging material 200 is the gender specifier. For example, thepackaging material 200 can be color coded to indicate gender, wherein a first color is used to indicate a female gender and a second color is used to indicate a male gender. The first and second color are selected from colors that are recognizable a gender indicators. For example, to indicate a female gender the first color can be the color pink and to indicate a male gender the second color can be the color blue. However, it is contemplated that first and second colors can be any colors which are readily discernable and indicators of gender. - Referring to
FIG. 26 , anexemplary medicine container 210 is provided, wherein themedicine container 210 includes alabel 212 affixed thereto. Thelabel 212 provides information identifying thecontents 214 and usage of the enclosed medicine. The usage information includes the recommend dosage for each gender, whereingender specifiers gender dosage information gender specifiers gender specifiers - In an alternative embodiment, a product insert can be provided in the
medicine container 210. Similar to thelabel 212, the product insert can provide information identifying the contents and usage of the enclosed medicine, which can include gender specifiers used in conjunction with dosage information. - Another technology that may be utilized to provide a gender-specific indicator is RFID chips. RFID chips may be associated with equipment, instruments, or in sterile packaging so that identification of the intended gender for the devices may be quickly determined. This may be of particular benefit where it is difficult to visually determine the gender-specific design. For example, it may be difficult to visually confirm the intended gender of light sensitive therapeutics, internal components, sealed materials, or implanted devices. Likewise, instrumentation kits may involve several tools or devices that would be time-consuming to confirm are all intended for the same gender. By associating an RFID tag with these devices, however, the gender-specific information can be quickly retrieved. In one embodiment, RFID chips provided in packaged gender-specific drugs are used to determine remaining quantities of medicine.
- All references cited herein are expressly incorporated by reference in their entirety.
- It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described herein above. In addition, unless mention was made above to the contrary, it should be noted that all of the accompanying drawings are not to scale. A variety of modifications and variations are possible in light of the above teachings without departing from the scope and spirit of the invention.
Claims (28)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/008,185 US20210000604A1 (en) | 2005-06-15 | 2020-08-31 | Gender specific pharmaceuticals |
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69065305P | 2005-06-15 | 2005-06-15 | |
US75580406P | 2006-01-03 | 2006-01-03 | |
US11/454,109 US9301845B2 (en) | 2005-06-15 | 2006-06-15 | Implant for knee replacement |
US15/003,243 US20160250029A1 (en) | 2005-06-15 | 2016-01-21 | Gender Specific Implant and Packaging |
US15/597,631 US20170266010A1 (en) | 2005-06-15 | 2017-05-17 | Gender Specific Implant and Packaging |
US16/376,626 US10806590B2 (en) | 2005-06-15 | 2019-04-05 | Methods and systems for providing gender specific pharmaceuticals |
US17/008,185 US20210000604A1 (en) | 2005-06-15 | 2020-08-31 | Gender specific pharmaceuticals |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/376,626 Continuation US10806590B2 (en) | 2005-06-15 | 2019-04-05 | Methods and systems for providing gender specific pharmaceuticals |
Publications (1)
Publication Number | Publication Date |
---|---|
US20210000604A1 true US20210000604A1 (en) | 2021-01-07 |
Family
ID=37574443
Family Applications (8)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/454,109 Active 2029-02-05 US9301845B2 (en) | 2005-06-15 | 2006-06-15 | Implant for knee replacement |
US15/003,243 Abandoned US20160250029A1 (en) | 2005-06-15 | 2016-01-21 | Gender Specific Implant and Packaging |
US15/071,965 Active US9750612B2 (en) | 2005-06-15 | 2016-03-16 | Methods and systems for providing gender specific pharmaceuticals |
US15/457,534 Abandoned US20170181799A1 (en) | 2005-06-15 | 2017-03-13 | Knee implant methods and systems |
US15/597,631 Abandoned US20170266010A1 (en) | 2005-06-15 | 2017-05-17 | Gender Specific Implant and Packaging |
US16/376,626 Active US10806590B2 (en) | 2005-06-15 | 2019-04-05 | Methods and systems for providing gender specific pharmaceuticals |
US17/008,185 Abandoned US20210000604A1 (en) | 2005-06-15 | 2020-08-31 | Gender specific pharmaceuticals |
US17/812,067 Pending US20220370206A1 (en) | 2005-06-15 | 2022-07-12 | Gender Specific Implant and Packaging |
Family Applications Before (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/454,109 Active 2029-02-05 US9301845B2 (en) | 2005-06-15 | 2006-06-15 | Implant for knee replacement |
US15/003,243 Abandoned US20160250029A1 (en) | 2005-06-15 | 2016-01-21 | Gender Specific Implant and Packaging |
US15/071,965 Active US9750612B2 (en) | 2005-06-15 | 2016-03-16 | Methods and systems for providing gender specific pharmaceuticals |
US15/457,534 Abandoned US20170181799A1 (en) | 2005-06-15 | 2017-03-13 | Knee implant methods and systems |
US15/597,631 Abandoned US20170266010A1 (en) | 2005-06-15 | 2017-05-17 | Gender Specific Implant and Packaging |
US16/376,626 Active US10806590B2 (en) | 2005-06-15 | 2019-04-05 | Methods and systems for providing gender specific pharmaceuticals |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/812,067 Pending US20220370206A1 (en) | 2005-06-15 | 2022-07-12 | Gender Specific Implant and Packaging |
Country Status (1)
Country | Link |
---|---|
US (8) | US9301845B2 (en) |
Families Citing this family (109)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080140212A1 (en) * | 2001-05-15 | 2008-06-12 | Robert Metzger | Elongated femoral component |
US8750983B2 (en) | 2004-09-20 | 2014-06-10 | P Tech, Llc | Therapeutic system |
US9301845B2 (en) * | 2005-06-15 | 2016-04-05 | P Tech, Llc | Implant for knee replacement |
US8211181B2 (en) * | 2005-12-14 | 2012-07-03 | New York University | Surface guided knee replacement |
AU2006325787B2 (en) * | 2005-12-15 | 2013-07-18 | Sergio Romagnoli | Distal femoral knee prostheses |
US8377066B2 (en) | 2006-02-27 | 2013-02-19 | Biomet Manufacturing Corp. | Patient-specific elbow guides and associated methods |
US9918740B2 (en) | 2006-02-27 | 2018-03-20 | Biomet Manufacturing, Llc | Backup surgical instrument system and method |
US8282646B2 (en) | 2006-02-27 | 2012-10-09 | Biomet Manufacturing Corp. | Patient specific knee alignment guide and associated method |
US8568487B2 (en) | 2006-02-27 | 2013-10-29 | Biomet Manufacturing, Llc | Patient-specific hip joint devices |
US8535387B2 (en) | 2006-02-27 | 2013-09-17 | Biomet Manufacturing, Llc | Patient-specific tools and implants |
US8591516B2 (en) | 2006-02-27 | 2013-11-26 | Biomet Manufacturing, Llc | Patient-specific orthopedic instruments |
US8603180B2 (en) | 2006-02-27 | 2013-12-10 | Biomet Manufacturing, Llc | Patient-specific acetabular alignment guides |
US8608748B2 (en) | 2006-02-27 | 2013-12-17 | Biomet Manufacturing, Llc | Patient specific guides |
US8241293B2 (en) | 2006-02-27 | 2012-08-14 | Biomet Manufacturing Corp. | Patient specific high tibia osteotomy |
US9173661B2 (en) | 2006-02-27 | 2015-11-03 | Biomet Manufacturing, Llc | Patient specific alignment guide with cutting surface and laser indicator |
US9289253B2 (en) | 2006-02-27 | 2016-03-22 | Biomet Manufacturing, Llc | Patient-specific shoulder guide |
US8070752B2 (en) | 2006-02-27 | 2011-12-06 | Biomet Manufacturing Corp. | Patient specific alignment guide and inter-operative adjustment |
US8133234B2 (en) | 2006-02-27 | 2012-03-13 | Biomet Manufacturing Corp. | Patient specific acetabular guide and method |
US8858561B2 (en) | 2006-06-09 | 2014-10-14 | Blomet Manufacturing, LLC | Patient-specific alignment guide |
US8864769B2 (en) | 2006-02-27 | 2014-10-21 | Biomet Manufacturing, Llc | Alignment guides with patient-specific anchoring elements |
US10278711B2 (en) | 2006-02-27 | 2019-05-07 | Biomet Manufacturing, Llc | Patient-specific femoral guide |
US9345548B2 (en) | 2006-02-27 | 2016-05-24 | Biomet Manufacturing, Llc | Patient-specific pre-operative planning |
US20150335438A1 (en) | 2006-02-27 | 2015-11-26 | Biomet Manufacturing, Llc. | Patient-specific augments |
US8608749B2 (en) | 2006-02-27 | 2013-12-17 | Biomet Manufacturing, Llc | Patient-specific acetabular guides and associated instruments |
US9113971B2 (en) | 2006-02-27 | 2015-08-25 | Biomet Manufacturing, Llc | Femoral acetabular impingement guide |
US8298237B2 (en) | 2006-06-09 | 2012-10-30 | Biomet Manufacturing Corp. | Patient-specific alignment guide for multiple incisions |
US8407067B2 (en) | 2007-04-17 | 2013-03-26 | Biomet Manufacturing Corp. | Method and apparatus for manufacturing an implant |
US8092465B2 (en) | 2006-06-09 | 2012-01-10 | Biomet Manufacturing Corp. | Patient specific knee alignment guide and associated method |
US9907659B2 (en) | 2007-04-17 | 2018-03-06 | Biomet Manufacturing, Llc | Method and apparatus for manufacturing an implant |
US7967868B2 (en) | 2007-04-17 | 2011-06-28 | Biomet Manufacturing Corp. | Patient-modified implant and associated method |
US9339278B2 (en) | 2006-02-27 | 2016-05-17 | Biomet Manufacturing, Llc | Patient-specific acetabular guides and associated instruments |
US8473305B2 (en) | 2007-04-17 | 2013-06-25 | Biomet Manufacturing Corp. | Method and apparatus for manufacturing an implant |
US9795399B2 (en) | 2006-06-09 | 2017-10-24 | Biomet Manufacturing, Llc | Patient-specific knee alignment guide and associated method |
US8600478B2 (en) | 2007-02-19 | 2013-12-03 | Medtronic Navigation, Inc. | Automatic identification of instruments used with a surgical navigation system |
US8265949B2 (en) | 2007-09-27 | 2012-09-11 | Depuy Products, Inc. | Customized patient surgical plan |
US8357111B2 (en) | 2007-09-30 | 2013-01-22 | Depuy Products, Inc. | Method and system for designing patient-specific orthopaedic surgical instruments |
ES2800031T3 (en) | 2007-09-30 | 2020-12-23 | Depuy Products Inc | Method for generating custom patient-specific orthopedic surgical instrumentation |
US8170641B2 (en) | 2009-02-20 | 2012-05-01 | Biomet Manufacturing Corp. | Method of imaging an extremity of a patient |
US9820853B2 (en) * | 2009-05-06 | 2017-11-21 | Biomet Manufacturing, Llc | Acetabular cup system |
CN102497837B (en) * | 2009-07-27 | 2015-12-02 | 托马斯·P·安瑞尔基 | Knee replacement system |
DE102009028503B4 (en) | 2009-08-13 | 2013-11-14 | Biomet Manufacturing Corp. | Resection template for the resection of bones, method for producing such a resection template and operation set for performing knee joint surgery |
US8632547B2 (en) | 2010-02-26 | 2014-01-21 | Biomet Sports Medicine, Llc | Patient-specific osteotomy devices and methods |
US9066727B2 (en) | 2010-03-04 | 2015-06-30 | Materialise Nv | Patient-specific computed tomography guides |
US8908937B2 (en) | 2010-07-08 | 2014-12-09 | Biomet Manufacturing, Llc | Method and device for digital image templating |
EP2588032B1 (en) | 2010-09-10 | 2014-10-22 | Zimmer GmbH | Femoral prothesis with medialized patellar groove |
US9271744B2 (en) | 2010-09-29 | 2016-03-01 | Biomet Manufacturing, Llc | Patient-specific guide for partial acetabular socket replacement |
US9968376B2 (en) | 2010-11-29 | 2018-05-15 | Biomet Manufacturing, Llc | Patient-specific orthopedic instruments |
US8917290B2 (en) | 2011-01-31 | 2014-12-23 | Biomet Manufacturing, Llc | Digital image templating |
US9241745B2 (en) | 2011-03-07 | 2016-01-26 | Biomet Manufacturing, Llc | Patient-specific femoral version guide |
US8715289B2 (en) | 2011-04-15 | 2014-05-06 | Biomet Manufacturing, Llc | Patient-specific numerically controlled instrument |
US9675400B2 (en) | 2011-04-19 | 2017-06-13 | Biomet Manufacturing, Llc | Patient-specific fracture fixation instrumentation and method |
US8956364B2 (en) | 2011-04-29 | 2015-02-17 | Biomet Manufacturing, Llc | Patient-specific partial knee guides and other instruments |
US8668700B2 (en) | 2011-04-29 | 2014-03-11 | Biomet Manufacturing, Llc | Patient-specific convertible guides |
US8532807B2 (en) | 2011-06-06 | 2013-09-10 | Biomet Manufacturing, Llc | Pre-operative planning and manufacturing method for orthopedic procedure |
US9084618B2 (en) | 2011-06-13 | 2015-07-21 | Biomet Manufacturing, Llc | Drill guides for confirming alignment of patient-specific alignment guides |
US9308095B2 (en) | 2011-06-16 | 2016-04-12 | Zimmer, Inc. | Femoral component for a knee prosthesis with improved articular characteristics |
US8551179B2 (en) | 2011-06-16 | 2013-10-08 | Zimmer, Inc. | Femoral prosthesis system having provisional component with visual indicators |
US8932365B2 (en) | 2011-06-16 | 2015-01-13 | Zimmer, Inc. | Femoral component for a knee prosthesis with improved articular characteristics |
US9060868B2 (en) | 2011-06-16 | 2015-06-23 | Zimmer, Inc. | Femoral component for a knee prosthesis with bone compacting ridge |
US20130001121A1 (en) | 2011-07-01 | 2013-01-03 | Biomet Manufacturing Corp. | Backup kit for a patient-specific arthroplasty kit assembly |
US8764760B2 (en) | 2011-07-01 | 2014-07-01 | Biomet Manufacturing, Llc | Patient-specific bone-cutting guidance instruments and methods |
US8597365B2 (en) | 2011-08-04 | 2013-12-03 | Biomet Manufacturing, Llc | Patient-specific pelvic implants for acetabular reconstruction |
US9295497B2 (en) | 2011-08-31 | 2016-03-29 | Biomet Manufacturing, Llc | Patient-specific sacroiliac and pedicle guides |
US9066734B2 (en) | 2011-08-31 | 2015-06-30 | Biomet Manufacturing, Llc | Patient-specific sacroiliac guides and associated methods |
US9386993B2 (en) | 2011-09-29 | 2016-07-12 | Biomet Manufacturing, Llc | Patient-specific femoroacetabular impingement instruments and methods |
US9451973B2 (en) | 2011-10-27 | 2016-09-27 | Biomet Manufacturing, Llc | Patient specific glenoid guide |
EP3384858A1 (en) | 2011-10-27 | 2018-10-10 | Biomet Manufacturing, LLC | Patient-specific glenoid guides |
US9301812B2 (en) | 2011-10-27 | 2016-04-05 | Biomet Manufacturing, Llc | Methods for patient-specific shoulder arthroplasty |
KR20130046336A (en) | 2011-10-27 | 2013-05-07 | 삼성전자주식회사 | Multi-view device of display apparatus and contol method thereof, and display system |
US9554910B2 (en) | 2011-10-27 | 2017-01-31 | Biomet Manufacturing, Llc | Patient-specific glenoid guide and implants |
US9237950B2 (en) | 2012-02-02 | 2016-01-19 | Biomet Manufacturing, Llc | Implant with patient-specific porous structure |
US9204977B2 (en) | 2012-12-11 | 2015-12-08 | Biomet Manufacturing, Llc | Patient-specific acetabular guide for anterior approach |
US9060788B2 (en) | 2012-12-11 | 2015-06-23 | Biomet Manufacturing, Llc | Patient-specific acetabular guide for anterior approach |
US9839438B2 (en) | 2013-03-11 | 2017-12-12 | Biomet Manufacturing, Llc | Patient-specific glenoid guide with a reusable guide holder |
US9579107B2 (en) | 2013-03-12 | 2017-02-28 | Biomet Manufacturing, Llc | Multi-point fit for patient specific guide |
US9498233B2 (en) | 2013-03-13 | 2016-11-22 | Biomet Manufacturing, Llc. | Universal acetabular guide and associated hardware |
US9826981B2 (en) | 2013-03-13 | 2017-11-28 | Biomet Manufacturing, Llc | Tangential fit of patient-specific guides |
US9517145B2 (en) | 2013-03-15 | 2016-12-13 | Biomet Manufacturing, Llc | Guide alignment system and method |
EP2967885B1 (en) | 2013-03-15 | 2016-12-14 | Mako Surgical Corporation | Knee implant |
DE102013205156B4 (en) | 2013-03-22 | 2015-02-12 | Heraeus Medical Gmbh | Knee spacer for temporary replacement of an artificial knee joint |
CN105431102B (en) | 2013-06-11 | 2018-01-30 | 迷你麦克斯医疗 | System for the processing of the amount of plan of body part |
US20150112349A1 (en) | 2013-10-21 | 2015-04-23 | Biomet Manufacturing, Llc | Ligament Guide Registration |
US10552574B2 (en) * | 2013-11-22 | 2020-02-04 | Spinal Generations, Llc | System and method for identifying a medical device |
US9827048B2 (en) | 2013-11-22 | 2017-11-28 | Spinal Generations, Llc | Integrated surgical implant delivery system and method |
US20150230926A1 (en) * | 2014-02-18 | 2015-08-20 | Biomet Manufacturing, Llc | Method and device for reducing implant contamination from handling |
US20150289984A1 (en) * | 2014-04-15 | 2015-10-15 | Matthew D. BUDGE | Total Shoulder Arthroplasty Prosthesis |
US10282488B2 (en) | 2014-04-25 | 2019-05-07 | Biomet Manufacturing, Llc | HTO guide with optional guided ACL/PCL tunnels |
US9408616B2 (en) | 2014-05-12 | 2016-08-09 | Biomet Manufacturing, Llc | Humeral cut guide |
US9561040B2 (en) | 2014-06-03 | 2017-02-07 | Biomet Manufacturing, Llc | Patient-specific glenoid depth control |
US9839436B2 (en) | 2014-06-03 | 2017-12-12 | Biomet Manufacturing, Llc | Patient-specific glenoid depth control |
US10130375B2 (en) | 2014-07-31 | 2018-11-20 | Zimmer, Inc. | Instruments and methods in performing kinematically-aligned total knee arthroplasty |
US9826994B2 (en) | 2014-09-29 | 2017-11-28 | Biomet Manufacturing, Llc | Adjustable glenoid pin insertion guide |
US9833245B2 (en) | 2014-09-29 | 2017-12-05 | Biomet Sports Medicine, Llc | Tibial tubercule osteotomy |
US9820868B2 (en) | 2015-03-30 | 2017-11-21 | Biomet Manufacturing, Llc | Method and apparatus for a pin apparatus |
US10226262B2 (en) | 2015-06-25 | 2019-03-12 | Biomet Manufacturing, Llc | Patient-specific humeral guide designs |
US10568647B2 (en) | 2015-06-25 | 2020-02-25 | Biomet Manufacturing, Llc | Patient-specific humeral guide designs |
EP3355834B1 (en) | 2015-09-29 | 2023-01-04 | Zimmer, Inc. | Tibial prosthesis for tibia with varus resection |
US10004564B1 (en) | 2016-01-06 | 2018-06-26 | Paul Beck | Accurate radiographic calibration using multiple images |
US10010372B1 (en) | 2016-01-06 | 2018-07-03 | Paul Beck | Marker Positioning Apparatus |
EP3426726A4 (en) | 2016-03-08 | 2020-03-04 | Ticona LLC | Orthopedic device and polymer compositions for making same |
EP3287150B1 (en) * | 2016-08-22 | 2022-12-14 | WALDEMAR LINK GmbH & Co. KG | Coating for an implant |
CN109983076A (en) | 2016-10-11 | 2019-07-05 | 塞拉尼斯销售德国有限公司 | With the abrasion-resistant polymers composition for improving appearance |
CA3046648A1 (en) * | 2016-12-13 | 2018-06-21 | Aurora Spine, Inc. | Body density scan result-matched orthopedic implants and methods of use |
US10195035B1 (en) * | 2016-12-30 | 2019-02-05 | Newtonoid Technologies, L.L.C. | Responsive biomechanical implants and devices |
US10722310B2 (en) | 2017-03-13 | 2020-07-28 | Zimmer Biomet CMF and Thoracic, LLC | Virtual surgery planning system and method |
US10022233B1 (en) | 2017-12-04 | 2018-07-17 | Duke University | Orthopedic implant for sustained drug release |
US11051829B2 (en) | 2018-06-26 | 2021-07-06 | DePuy Synthes Products, Inc. | Customized patient-specific orthopaedic surgical instrument |
CN109481105A (en) * | 2018-11-01 | 2019-03-19 | 镁荷津生物科技(上海)有限公司 | A kind of sealer and manufacturing method and angiocarpy bracket with compression |
CN116035779B (en) * | 2023-03-30 | 2023-07-28 | 北京爱康宜诚医疗器材有限公司 | Assembled semi-elbow joint prosthesis |
Family Cites Families (192)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4820547B1 (en) | 1970-01-22 | 1973-06-21 | ||
US3837478A (en) * | 1970-04-30 | 1974-09-24 | Grip Pak Inc | Stretchable packaging device for containers |
US3627122A (en) * | 1970-06-01 | 1971-12-14 | Robert Richard Garbe Jr | System and apparatus for the administration of drugs |
US4081866A (en) | 1977-02-02 | 1978-04-04 | Howmedica, Inc. | Total anatomical knee prosthesis |
US4340978A (en) | 1979-07-02 | 1982-07-27 | Biomedical Engineering Corp. | New Jersey meniscal bearing knee replacement |
US4457307A (en) | 1982-08-20 | 1984-07-03 | Stillwell William T | Bone cutting device for total knee replacement |
CH657268A5 (en) | 1983-03-23 | 1986-08-29 | Sulzer Ag | Femme part for a knee joint prosthesis. |
DE3315401A1 (en) | 1983-04-28 | 1984-10-31 | Feldmühle AG, 4000 Düsseldorf | Knee-joint prosthesis |
US4944760A (en) * | 1983-10-26 | 1990-07-31 | Pfizer Hospital Products Group, Inc. | Method and instrumentation for the replacement of a knee prosthesis |
US4822365A (en) | 1986-05-30 | 1989-04-18 | Walker Peter S | Method of design of human joint prosthesis |
JPS6468255A (en) | 1987-08-10 | 1989-03-14 | Dow Corning Wright Corp | Artificial device for composing thighbone in knee joint |
US4750619A (en) | 1987-08-10 | 1988-06-14 | Osteonics Corp. | Package with tray for securing and presenting a sterile prosthetic implant element |
JPS6449908A (en) | 1987-08-20 | 1989-02-27 | Mitutoyo Corp | Method and instrument for measuring surface roughness |
US4944756A (en) | 1988-02-03 | 1990-07-31 | Pfizer Hospital Products Group | Prosthetic knee joint with improved patellar component tracking |
US4883180A (en) * | 1988-06-09 | 1989-11-28 | Essie Mae Humphrey | Color coded medicine caps and labels for daily dosage |
GR1000566B (en) | 1988-12-27 | 1992-08-26 | Johnson & Johnson Orthopaedics | Independent knee prosthesis which can be replaced |
US5007933A (en) | 1989-01-31 | 1991-04-16 | Osteonics Corp. | Modular knee prosthesis system |
US5061271A (en) | 1989-02-27 | 1991-10-29 | Boehringer Mannheim Corporation | Tool for separating components of a modular joint prosthesis |
US4938769A (en) * | 1989-05-31 | 1990-07-03 | Shaw James A | Modular tibial prosthesis |
US4976351A (en) * | 1989-06-01 | 1990-12-11 | Pharmedix | Kit for distributing pharmaceutical products |
JPH03267055A (en) | 1990-03-16 | 1991-11-27 | Koshino Nariko | Shank side component of artificial knee joint |
US5148920A (en) | 1991-03-18 | 1992-09-22 | Zimmer, Inc. | Package and package insert |
US5193679A (en) | 1991-07-10 | 1993-03-16 | Smith & Nephew Richards Inc. | Package for hip prosthesis |
JPH0553501A (en) | 1991-08-26 | 1993-03-05 | Sumitomo Electric Ind Ltd | Optimum course determining method using course table |
JPH0568987A (en) | 1991-09-11 | 1993-03-23 | Matsushita Electric Ind Co Ltd | Rainwater purifying apparatus |
US5133758A (en) | 1991-09-16 | 1992-07-28 | Research And Education Institute, Inc. Harbor-Ucla Medical Center | Total knee endoprosthesis with fixed flexion-extension axis of rotation |
US5282861A (en) | 1992-03-11 | 1994-02-01 | Ultramet | Open cell tantalum structures for cancellous bone implants and cell and tissue receptors |
US5226915A (en) * | 1992-04-03 | 1993-07-13 | Bertin Kim C | Femoral prosthesis component system for knee replacement surgery |
EP0567705B1 (en) | 1992-04-30 | 1997-07-09 | Merck Biomaterial France | Posteriorly stabilized total knee prosthesis |
US5445642A (en) | 1992-09-01 | 1995-08-29 | Depuy Inc. | Method for installing a femoral component |
US5356006A (en) | 1992-12-16 | 1994-10-18 | Ethicon, Inc. | Sterile package for surgical devices |
US5728162A (en) | 1993-01-28 | 1998-03-17 | Board Of Regents Of University Of Colorado | Asymmetric condylar and trochlear femoral knee component |
US5366006A (en) * | 1993-03-01 | 1994-11-22 | Mccord Heat Transfer Corporation | Tab joint between coolant tube and header |
JP3267055B2 (en) | 1994-05-31 | 2002-03-18 | 三菱マテリアル株式会社 | Pure Au powder for producing pure gold clay with excellent sinterability |
US5549686A (en) | 1994-06-06 | 1996-08-27 | Zimmer, Inc. | Knee prosthesis having a tapered cam |
FR2721500B1 (en) | 1994-06-22 | 1996-12-06 | Euros Sa | Femoral implant, in particular for a three-compartment knee prosthesis. |
US5549688A (en) | 1994-08-04 | 1996-08-27 | Smith & Nephew Richards Inc. | Asymmetric femoral prosthesis |
US5755803A (en) | 1994-09-02 | 1998-05-26 | Hudson Surgical Design | Prosthetic implant |
US5597384A (en) * | 1994-09-13 | 1997-01-28 | Zimmer, Inc. | Color coding for implant selection |
AUPN089495A0 (en) | 1995-02-03 | 1995-03-02 | Denupo Pty. Ltd. | Knee prosthesis |
US5639279A (en) | 1995-02-09 | 1997-06-17 | Intermedics Orthopedics, Inc. | Posteriorly-stabilized prosthetic knee |
US5609643A (en) | 1995-03-13 | 1997-03-11 | Johnson & Johnson Professional, Inc. | Knee joint prosthesis |
FR2737970B1 (en) | 1995-08-23 | 1998-01-09 | Chibrac Jean | JOINT PROSTHESIS ELEMENTS AND MANUFACTURING METHOD THEREOF |
US6540786B2 (en) | 1995-08-23 | 2003-04-01 | Jean Chibrac | Joint prosthesis members and method for making same |
JP3469972B2 (en) | 1995-09-29 | 2003-11-25 | 京セラ株式会社 | Artificial knee joint |
US5871546A (en) | 1995-09-29 | 1999-02-16 | Johnson & Johnson Professional, Inc. | Femoral component condyle design for knee prosthesis |
US5776201A (en) * | 1995-10-02 | 1998-07-07 | Johnson & Johnson Professional, Inc. | Modular femoral trial system |
US6021377A (en) | 1995-10-23 | 2000-02-01 | Baker Hughes Incorporated | Drilling system utilizing downhole dysfunctions for determining corrective actions and simulating drilling conditions |
DE19544162C1 (en) | 1995-11-17 | 1997-04-24 | Ethicon Gmbh | Implant for suspension of the bladder in urinary incontinence in women |
JP3495161B2 (en) | 1995-11-30 | 2004-02-09 | 京セラ株式会社 | Femoral component of a knee prosthesis |
US5681354A (en) | 1996-02-20 | 1997-10-28 | Board Of Regents, University Of Colorado | Asymmetrical femoral component for knee prosthesis |
US6318555B1 (en) | 1996-06-27 | 2001-11-20 | Kimberly-Clark Worldwide, Inc. | Flexible packaging bag with visual display feature |
US6126690A (en) | 1996-07-03 | 2000-10-03 | The Trustees Of Columbia University In The City Of New York | Anatomically correct prosthesis and method and apparatus for manufacturing prosthesis |
US5964808A (en) | 1996-07-11 | 1999-10-12 | Wright Medical Technology, Inc. | Knee prosthesis |
US5762125A (en) | 1996-09-30 | 1998-06-09 | Johnson & Johnson Professional, Inc. | Custom bioimplantable article |
US7618451B2 (en) | 2001-05-25 | 2009-11-17 | Conformis, Inc. | Patient selectable joint arthroplasty devices and surgical tools facilitating increased accuracy, speed and simplicity in performing total and partial joint arthroplasty |
US20090222103A1 (en) | 2001-05-25 | 2009-09-03 | Conformis, Inc. | Articular Implants Providing Lower Adjacent Cartilage Wear |
US8882847B2 (en) | 2001-05-25 | 2014-11-11 | Conformis, Inc. | Patient selectable knee joint arthroplasty devices |
US8545569B2 (en) | 2001-05-25 | 2013-10-01 | Conformis, Inc. | Patient selectable knee arthroplasty devices |
US7468075B2 (en) | 2001-05-25 | 2008-12-23 | Conformis, Inc. | Methods and compositions for articular repair |
US20070233269A1 (en) | 2001-05-25 | 2007-10-04 | Conformis, Inc. | Interpositional Joint Implant |
US7534263B2 (en) | 2001-05-25 | 2009-05-19 | Conformis, Inc. | Surgical tools facilitating increased accuracy, speed and simplicity in performing joint arthroplasty |
US7799077B2 (en) | 2002-10-07 | 2010-09-21 | Conformis, Inc. | Minimally invasive joint implant with 3-dimensional geometry matching the articular surfaces |
GB9707717D0 (en) | 1997-04-16 | 1997-06-04 | Walker Peter S | Knee prosthesis having guide surfaces for control of anterior-posterior translation |
US6571790B1 (en) * | 1997-05-12 | 2003-06-03 | Robert E. Weinstein | Method and device for organizing and coordinating the combined use of liquid medications for continuous nebulization for the treatment of respiratory disorders |
US6039764A (en) | 1997-08-18 | 2000-03-21 | Arch Development Corporation | Prosthetic knee with adjusted center of internal/external rotation |
US6258126B1 (en) * | 1997-09-09 | 2001-07-10 | Depuy Orthopaedics, Inc. | Cushioned joint prosthesis |
AU2895899A (en) | 1998-03-04 | 1999-09-20 | Medtronic, Inc. | Medical device packaging system |
CA2266198A1 (en) | 1998-03-20 | 1999-09-20 | Baker Hughes Incorporated | Thruster responsive to drilling parameters |
US6616696B1 (en) | 1998-09-04 | 2003-09-09 | Alan C. Merchant | Modular knee replacement system |
US6152960A (en) | 1998-10-13 | 2000-11-28 | Biomedical Engineering Trust I | Femoral component for knee endoprosthesis |
FR2784577B1 (en) | 1998-10-16 | 2001-03-09 | Depuy France | FEMALE IMPLANT FOR KNEE PROSTHESIS |
US6106529A (en) | 1998-12-18 | 2000-08-22 | Johnson & Johnson Professional, Inc. | Epicondylar axis referencing drill guide |
US6269892B1 (en) | 1998-12-21 | 2001-08-07 | Dresser Industries, Inc. | Steerable drilling system and method |
DE29906909U1 (en) | 1999-03-02 | 1999-09-30 | Plus Endoprothetik Ag, Rotkreuz | Femur sledge |
FR2791553B1 (en) | 1999-04-01 | 2001-07-06 | Merck Biomaterial France | ANTERO-POSTERO-STABILIZED KNEE PROSTHESIS |
FR2796836B1 (en) | 1999-07-26 | 2002-03-22 | Michel Bercovy | NEW KNEE PROSTHESIS |
US6471060B1 (en) * | 2000-01-12 | 2002-10-29 | Leyshon Miller Industries, Inc. | Doll case |
FR2805455B1 (en) | 2000-02-24 | 2002-04-19 | Aesculap Sa | FEMORAL COMPONENT OF A THREE-BEND KNEE PROSTHESIS |
US6712856B1 (en) | 2000-03-17 | 2004-03-30 | Kinamed, Inc. | Custom replacement device for resurfacing a femur and method of making the same |
SE519763C2 (en) | 2000-07-03 | 2003-04-08 | Bofors Weapon Sys Ab | Arrangements to meet combatability of targets with function with directed blasting effect |
FR2815244B1 (en) | 2000-10-18 | 2003-06-27 | Aesculap Sa | INCLINED FEMORAL COMPONENT |
US6719800B2 (en) | 2001-01-29 | 2004-04-13 | Zimmer Technology, Inc. | Constrained prosthetic knee with rotating bearing |
KR20030082942A (en) | 2001-02-27 | 2003-10-23 | 스미스 앤드 네퓨, 인크. | Total knee arthroplasty systems and processes |
US8062377B2 (en) | 2001-03-05 | 2011-11-22 | Hudson Surgical Design, Inc. | Methods and apparatus for knee arthroplasty |
US6589283B1 (en) | 2001-05-15 | 2003-07-08 | Biomet, Inc. | Elongated femoral component |
US20080140212A1 (en) | 2001-05-15 | 2008-06-12 | Robert Metzger | Elongated femoral component |
DE60239674D1 (en) | 2001-05-25 | 2011-05-19 | Conformis Inc | METHOD AND COMPOSITIONS FOR REPAIRING THE SURFACE OF JOINTS |
US7892288B2 (en) | 2001-08-27 | 2011-02-22 | Zimmer Technology, Inc. | Femoral augments for use with knee joint prosthesis |
US20040208832A1 (en) * | 2001-11-02 | 2004-10-21 | Bates Michael Timothy | Color-coded therapy unit |
US6901304B2 (en) * | 2002-01-11 | 2005-05-31 | Sap Aktiengesellschaft | Item tracking system architectures providing real-time visibility to supply chain |
WO2003070127A1 (en) | 2002-02-20 | 2003-08-28 | Nemcomed, Ltd. | Knee arthroplasty prosthesis and method |
US20030196929A1 (en) * | 2002-04-19 | 2003-10-23 | Govindan Gopinathan | Pharmaceutical kit for migraine headache treatment |
FR2838634B1 (en) | 2002-04-19 | 2004-06-18 | Cabinet Boettcher | TOTAL KNEE PROSTHESIS |
DE10220591B4 (en) | 2002-05-08 | 2004-03-18 | Mathys Medizinaltechnik Ag | Joint prosthesis with an intermediate element with different radii of curvature |
US20030225458A1 (en) | 2002-06-04 | 2003-12-04 | Ron Donkers | Universal femoral component for endoprosthetic knee |
EP1528902B1 (en) | 2002-08-15 | 2006-11-15 | Symbios Orthopédie SA | Knee prosthesis |
WO2004017375A2 (en) * | 2002-08-16 | 2004-02-26 | Plastech, Inc. | Multi-component packaging system and method for manufacture |
US20040031722A1 (en) * | 2002-08-19 | 2004-02-19 | Marlene Reed | Thematic candle card set |
US6827739B2 (en) | 2002-08-26 | 2004-12-07 | Zimmer Technology, Inc. | Easily assembled provisional orthopaedic implant |
US20040045863A1 (en) * | 2002-09-06 | 2004-03-11 | Rhoades Dean L. | Container with extractable and retractable instructions |
EP1558181B1 (en) | 2002-11-07 | 2015-08-26 | ConforMIS, Inc. | Methods for determining meniscal size and shape and for devising treatment |
JP4148316B2 (en) | 2002-11-18 | 2008-09-10 | 株式会社神戸製鋼所 | Artificial knee joint |
US20040102852A1 (en) | 2002-11-22 | 2004-05-27 | Johnson Erin M. | Modular knee prosthesis |
KR20050072500A (en) | 2002-12-04 | 2005-07-11 | 콘포미스 인코퍼레이티드 | Fusion of multiple imaging planes for isotropic imaging in mri and quantitative image analysis using isotropic or near-isotropic imaging |
DE60336013D1 (en) | 2002-12-20 | 2011-03-24 | Smith & Nephew Inc | HIGH POWER KNEE PROSTHESIS |
US6988009B2 (en) | 2003-02-04 | 2006-01-17 | Zimmer Technology, Inc. | Implant registration device for surgical navigation system |
FR2854792B1 (en) | 2003-05-12 | 2005-09-09 | Tornier Sa | GAME OF PROTHETIC ELEMENTS FOR A TIBIAL PROTHETIC SET |
EP1477142A3 (en) | 2003-05-13 | 2005-01-05 | Privelop AG | Endoprosthesis of the knee |
CA2527778C (en) | 2003-06-13 | 2011-11-08 | Tyco Healthcare Group Lp | Multiple member interconnect for surgical instrument and absorbable screw fastener |
US7081137B1 (en) | 2003-06-23 | 2006-07-25 | Howmedica Osteonics Corp. | Knee prosthesis with extended range of motion |
US20050029156A1 (en) * | 2003-08-08 | 2005-02-10 | Pfizer Inc | Customized medication organizer |
CA2542619C (en) | 2003-10-17 | 2011-10-11 | Smith & Nephew, Inc. | High flexion articular insert |
US7387644B2 (en) | 2003-11-07 | 2008-06-17 | University Of Vermont And State Agricultural College | Knee joint prosthesis with a femoral component which links the tibiofemoral axis of rotation with the patellofemoral axis of rotation |
EP1722721A1 (en) | 2004-01-23 | 2006-11-22 | Massachusetts General Hospital | Anterior cruciate ligament substituting knee replacement prosthesis |
US7442196B2 (en) | 2004-02-06 | 2008-10-28 | Synvasive Technology, Inc. | Dynamic knee balancer |
US7263947B2 (en) * | 2004-02-24 | 2007-09-04 | Harry Giewercer | Extended use reminder device |
US20050240441A1 (en) * | 2004-04-26 | 2005-10-27 | Olympus Corporation | Hospital information system and program thereof |
US7465320B1 (en) | 2004-05-06 | 2008-12-16 | Biomet Manufacturing Corp. | Knee joint prosthesis |
FR2871368B1 (en) * | 2004-06-15 | 2006-08-25 | Tornier Sas | SET OF HUMERAL COMPONENTS FOR TOTAL SHOULDER PROSTHESIS |
FR2871678B1 (en) | 2004-06-17 | 2006-09-01 | Transysteme Sa | TOTAL KNEE PROSTHESIS |
US7662156B2 (en) | 2004-06-22 | 2010-02-16 | Smith & Nephew, Inc. | Systems and processes for determining proper superior-inferior joint line positioning |
US20060042990A1 (en) * | 2004-08-24 | 2006-03-02 | Galuten Jerry H | Medication kit |
US20060085078A1 (en) | 2004-10-20 | 2006-04-20 | Steffensmeier Scott J | Mobile bearing unicondylar knee prosthesis |
US20060111722A1 (en) | 2004-11-19 | 2006-05-25 | Hacene Bouadi | Surgical cutting tool |
US20060224244A1 (en) | 2005-03-31 | 2006-10-05 | Zimmer Technology, Inc. | Hydrogel implant |
US20060235541A1 (en) | 2005-04-15 | 2006-10-19 | Zimmer Technology, Inc. | Bearing implant |
US20060235542A1 (en) | 2005-04-15 | 2006-10-19 | Zimmer Technology, Inc. | Flexible segmented bearing implant |
US9301845B2 (en) * | 2005-06-15 | 2016-04-05 | P Tech, Llc | Implant for knee replacement |
US20070028491A1 (en) * | 2005-07-13 | 2007-02-08 | Panella Michael J | System to code and identify beverage containers |
US7955394B2 (en) | 2005-07-14 | 2011-06-07 | Saga University | Artificial knee joint |
EP1754456B1 (en) | 2005-08-16 | 2008-06-18 | Zimmer GmbH | Surgical system. |
US20080288080A1 (en) | 2005-08-24 | 2008-11-20 | Kantilal Hastimal Sancheti | Knee joint prosthesis |
CN101325926A (en) | 2005-08-24 | 2008-12-17 | 坎蒂拉尔·哈斯蒂马尔·桑切蒂 | Knee joint prosthesis |
US7413577B1 (en) | 2005-09-22 | 2008-08-19 | Howmedica Osteonics Corp. | Total stabilized knee prosthesis with constraint |
US20070088444A1 (en) | 2005-10-13 | 2007-04-19 | Robert A Hodorek | Method for repairing a bone defect using a formable implant which hardens in vivo |
US20070123984A1 (en) | 2005-10-26 | 2007-05-31 | Zimmer Technology, Inc. | Ligament attachment and repair device |
CA2640759A1 (en) | 2005-11-09 | 2007-05-18 | Zimmer Gmbh | Implant |
US8211181B2 (en) | 2005-12-14 | 2012-07-03 | New York University | Surface guided knee replacement |
US20080058947A1 (en) | 2005-12-15 | 2008-03-06 | Zimmer, Inc. | Distal femoral knee prostheses |
AU2006325787B2 (en) | 2005-12-15 | 2013-07-18 | Sergio Romagnoli | Distal femoral knee prostheses |
US20070179607A1 (en) | 2006-01-31 | 2007-08-02 | Zimmer Technology, Inc. | Cartilage resurfacing implant |
CA2646288A1 (en) | 2006-03-21 | 2007-09-27 | Conformis, Inc. | Interpositional joint implant |
US9168156B2 (en) | 2006-04-04 | 2015-10-27 | Smith & Nephew, Inc. | Trial coupler systems and methods |
GR1005477B (en) | 2006-04-07 | 2007-03-26 | Total knee arthroplasty consisting in the use of an internal prosthesis composed of a third condylus and a pivoting polyethylene insert | |
GB0607544D0 (en) | 2006-04-13 | 2006-05-24 | Pinskerova Vera | Knee prothesis |
FR2901689B1 (en) | 2006-05-30 | 2008-08-08 | Dedienne Sante Sa | TOTAL KNEE JOINT PROSTHESIS |
FR2901995B1 (en) | 2006-06-12 | 2008-08-29 | Jean Francois Biegun | PROTHESIS TRICOMPARTIMENT A REINFORCEMENT |
FR2901996B1 (en) | 2006-06-12 | 2008-08-22 | Jean Francois Biegun | FEMORAL COMPONENT FOR RIGHT OR LEFT KNEE |
US20080000786A1 (en) * | 2006-06-30 | 2008-01-03 | Steven Collotta | Combination Ingestible-Product and Beverage Packaging |
CN101646392B (en) | 2006-10-31 | 2013-05-22 | 史密夫和内修有限公司 | Trial femoral prosthesis and its use |
US7582118B2 (en) | 2007-02-06 | 2009-09-01 | Zimmer Technology, Inc. | Femoral trochlea prostheses |
US8128704B2 (en) | 2007-02-06 | 2012-03-06 | Zimmer, Inc. | Femoral trochlea prostheses |
US20080281428A1 (en) | 2007-05-07 | 2008-11-13 | Zimmer, Inc. | Methods and apparatuses for attaching soft tissue to orthopaedic implants |
US7947066B2 (en) | 2007-05-22 | 2011-05-24 | K2M, Inc. | Universal transverse connector device |
US8382846B2 (en) | 2007-08-27 | 2013-02-26 | Kent M. Samuelson | Systems and methods for providing deeper knee flexion capabilities for knee prosthesis patients |
DE202007014128U1 (en) | 2007-10-09 | 2008-01-10 | Kloss, Henning | Knee endoprosthesis |
DE202007014126U1 (en) | 2007-10-09 | 2008-01-03 | Wodtke Gmbh | Exhaust gas heat exchanger of a fireplace |
JP4369972B2 (en) | 2007-12-26 | 2009-11-25 | 古河電気工業株式会社 | Subscriber premises optical line termination equipment |
KR100901524B1 (en) | 2008-01-08 | 2009-06-08 | 주식회사 코렌텍 | Artificial knee joint apparatus having plural curvatures at a femoral component |
KR100901528B1 (en) | 2008-01-08 | 2009-06-08 | 주식회사 코렌텍 | Artificial knee joint apparatus for preventing from damaging ligament |
KR100930727B1 (en) | 2008-01-08 | 2009-12-09 | 주식회사 코렌텍 | Artificial knee joint with improved post and improved cam structure |
CN102006839B (en) | 2008-02-18 | 2014-07-23 | 麦克斯外科整形公司 | Total knee replacement prosthesis |
JP5665550B2 (en) | 2008-02-18 | 2015-02-04 | マックス オーソピディックス、インク. | Total replacement artificial knee joint with higher-order NURBS curved surface |
WO2009126967A1 (en) * | 2008-04-11 | 2009-10-15 | Pediadermics, Llc | Systems and methods for treatment kits |
US8696755B2 (en) | 2008-04-17 | 2014-04-15 | Steven L. Mandell | Tibial component of an artificial knee joint |
US8790411B2 (en) | 2008-04-17 | 2014-07-29 | Steven L. Mandell | Femoral component of an artificial knee joint |
CN102076283B (en) | 2008-06-24 | 2014-03-26 | 彼得·斯坦利·沃克 | Recess-ramp knee joint prosthesis |
US8828086B2 (en) | 2008-06-30 | 2014-09-09 | Depuy (Ireland) | Orthopaedic femoral component having controlled condylar curvature |
US8236061B2 (en) | 2008-06-30 | 2012-08-07 | Depuy Products, Inc. | Orthopaedic knee prosthesis having controlled condylar curvature |
US8187335B2 (en) | 2008-06-30 | 2012-05-29 | Depuy Products, Inc. | Posterior stabilized orthopaedic knee prosthesis having controlled condylar curvature |
US8192498B2 (en) | 2008-06-30 | 2012-06-05 | Depuy Products, Inc. | Posterior cructiate-retaining orthopaedic knee prosthesis having controlled condylar curvature |
US8206451B2 (en) | 2008-06-30 | 2012-06-26 | Depuy Products, Inc. | Posterior stabilized orthopaedic prosthesis |
US8075626B2 (en) | 2008-06-30 | 2011-12-13 | Depuy Products, Inc. | Orthopaedic knee prosthesis having increased axial-rotation |
US20100161067A1 (en) | 2008-12-23 | 2010-06-24 | Aesculap Ag | Knee prosthesis |
WO2010088383A1 (en) | 2009-01-29 | 2010-08-05 | Zimmer, Inc. | Apparatus and method for the extramedullary location of the mechanical axis of a femur |
EP2410950B1 (en) | 2009-03-27 | 2015-05-13 | Smith & Nephew Orthopaedics AG | Artificial knee joint |
CN102497837B (en) | 2009-07-27 | 2015-12-02 | 托马斯·P·安瑞尔基 | Knee replacement system |
US10058117B2 (en) * | 2009-11-23 | 2018-08-28 | Randall Scott Hickle | Dietary health food composition, package and method of use |
EP2509539B1 (en) | 2009-12-11 | 2020-07-01 | ConforMIS, Inc. | Patient-specific and patient-engineered orthopedic implants |
US8771280B2 (en) | 2010-03-08 | 2014-07-08 | Zimmer, Inc. | Femoral cut guide |
EP2588032B1 (en) | 2010-09-10 | 2014-10-22 | Zimmer GmbH | Femoral prothesis with medialized patellar groove |
WO2012112702A2 (en) | 2011-02-15 | 2012-08-23 | Conformis, Inc. | Patient-adapted and improved articular implants, designs and related guide tools |
US8932365B2 (en) | 2011-06-16 | 2015-01-13 | Zimmer, Inc. | Femoral component for a knee prosthesis with improved articular characteristics |
US9308095B2 (en) | 2011-06-16 | 2016-04-12 | Zimmer, Inc. | Femoral component for a knee prosthesis with improved articular characteristics |
CA3065220A1 (en) | 2011-06-16 | 2012-12-20 | Zimmer, Inc. | Femoral component for a knee prosthesis with improved articular characteristics |
US8551179B2 (en) | 2011-06-16 | 2013-10-08 | Zimmer, Inc. | Femoral prosthesis system having provisional component with visual indicators |
US9060868B2 (en) | 2011-06-16 | 2015-06-23 | Zimmer, Inc. | Femoral component for a knee prosthesis with bone compacting ridge |
US8968412B2 (en) | 2011-06-30 | 2015-03-03 | Depuy (Ireland) | Trialing system for a knee prosthesis and method of use |
US8951301B2 (en) | 2011-06-30 | 2015-02-10 | Depuy (Ireland) | Method of using a trialing system for a knee prosthesis |
US8986390B2 (en) | 2011-06-30 | 2015-03-24 | Depuy (Ireland) | Method of trialing a knee prosthesis |
US20130006378A1 (en) | 2011-06-30 | 2013-01-03 | Wogoman Thomas E | Polymer femoral trial component |
-
2006
- 2006-06-15 US US11/454,109 patent/US9301845B2/en active Active
-
2016
- 2016-01-21 US US15/003,243 patent/US20160250029A1/en not_active Abandoned
- 2016-03-16 US US15/071,965 patent/US9750612B2/en active Active
-
2017
- 2017-03-13 US US15/457,534 patent/US20170181799A1/en not_active Abandoned
- 2017-05-17 US US15/597,631 patent/US20170266010A1/en not_active Abandoned
-
2019
- 2019-04-05 US US16/376,626 patent/US10806590B2/en active Active
-
2020
- 2020-08-31 US US17/008,185 patent/US20210000604A1/en not_active Abandoned
-
2022
- 2022-07-12 US US17/812,067 patent/US20220370206A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20170181799A1 (en) | 2017-06-29 |
US20060287733A1 (en) | 2006-12-21 |
US20160250029A1 (en) | 2016-09-01 |
US10806590B2 (en) | 2020-10-20 |
US20160206509A1 (en) | 2016-07-21 |
US20220370206A1 (en) | 2022-11-24 |
US20170266010A1 (en) | 2017-09-21 |
US9301845B2 (en) | 2016-04-05 |
US20190231542A1 (en) | 2019-08-01 |
US9750612B2 (en) | 2017-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10806590B2 (en) | Methods and systems for providing gender specific pharmaceuticals | |
Sporer et al. | The use of structural distal femoral allografts for acetabular reconstruction: average ten-year follow-up | |
Parker et al. | Arthroplasties (with and without bone cement) for proximal femoral fractures in adults | |
Dorr et al. | Ten years of experience with porous acetabular components for revision surgery. | |
Christie et al. | Primary total hip arthroplasty with use of the modular S-ROM prosthesis. Four to seven-year clinical and radiographic results | |
Lewthwaite et al. | The Exeter™ Universal Hip in patients 50 years or younger at 10-17 years' followup | |
Lynch et al. | Self-assessed outcome at two to four years after shoulder hemiarthroplasty with concentric glenoid reaming | |
Cho et al. | Knee joint arthroplasty | |
Cheung et al. | Total elbow prosthesis loosening caused by ulnar component pistoning | |
Han et al. | Brief followup report: does high-flexion total knee arthroplasty allow deep flexion safely in Asian patients? | |
Harwin et al. | Cementless posteriorly stabilized total knee arthroplasty: seven-year minimum follow-up report | |
Branson et al. | Primary total hip arthroplasty | |
Ong et al. | Role of surgical position on interface stress and initial bone remodeling stimulus around hip resurfacing arthroplasty | |
Beaulé et al. | Survivorship analysis of cementless total hip arthroplasty in younger patients | |
Okumura et al. | A case report of idiopathic iliopsoas hematoma which occurred soon after transfer to the wheelchair after total hip arthroplasty | |
Freeman | Hydroxyapatite coating of prostheses | |
Fuchs et al. | 10-year follow-up of the Columbus knee prostheses system in a prospective multicenter study | |
Wickramasinghe | 3D Printing in Healthcare: Opportunities, Benefits, Barriers, and Facilitators | |
Branson et al. | Sequential bilateral total knee arthroplasty | |
Zinar et al. | Why hip implants fail: Patient, surgeon, or device? | |
Lal et al. | Evolving Trends in Total Knee Arthroplasty | |
Manjunath | Evaluation of Clinical and Functional Outcome of Primary Total Hip Replacement–A Prospective Study | |
Delfosse et al. | TKA Component Design: What Do Engineers Need to Know? | |
Patel et al. | Müller straight stem total hip arthroplasty for fractured neck of femur | |
Shaji | Types of implants and evaluation of quality of life in knee replacement patient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: P TECH, LLC, FLORIDA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BONUTTI, PETER M.;REEL/FRAME:053877/0019 Effective date: 20200916 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: ADVISORY ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |